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ABSTRACT 
Introduction and aims: Cigarette smoking is an important risk factor for cardiovascular 
disease, and nicotine, the addictive substance in tobacco, is implicated in the pathogenesis of 
atherosclerosis via oxidative stress.  Oxidative stress can lead to loss of vascular homeostasis, 
via reduced nitric oxide (NO) bioavailability, which in turns leads to endothelial dysfunction. 
Endothelial dysfunction is an early, reversible precursor of atherosclerosis and cardiovascular 
disease. This dissertation aimed to investigate whether treatment with the indigenous South 
African plant rooibos (fermented and unfermented) and the hormone melatonin can ameliorate 
the harmful effects of nicotine on the vascular and endothelial systems.   
Methodology: This study made use of an in vivo model (male Wistar rats) and ex vivo model 
(rat aortic ring segments), complemented by an in vitro model of cultured rat aortic endothelial 
cells (AECs).  Biometric data, fluid intakes, blood pressure measurements, vascular function, 
antioxidant/oxidative stress status, inflammatory markers and serum lipids were determined 
as measures of the effects of nicotine (5 mg/kg bw/day; subcutaneously administered) in the 
rat model.  The effects of nicotine co-treated with rooibos (2% administered as drinking fluid) 
and nicotine co-treated with melatonin (4 mg/kg bw/day; administered as drinking fluid) were 
assessed according to the same endpoints to determine if the nicotine-induced effects 
observed could be ameliorated.  The modulating effects of fermented rooibos (RF) were 
further investigated in an in vitro model of AECs.  Nicotine injury (100 µM over a 24 hour 
treatment period) was assessed by means of NO production and cell viability assays.  The 
effects of nicotine, pre-treated with RF (0.015 mg/ml) were assessed according to the same 
endpoints. 
Results: Nicotine-induced vascular injury: Nicotine treatment (six weeks) in rats exerted 
significant effects on biometric parameters, reduced fluid consumption, increased blood 
pressure, and elicited pro-contractile responses in aortic rings.  Furthermore, nicotine 
administration led to a decrease in superoxide dismutase (SOD) activity (liver) and catalase 
(CAT) activity (heart and liver), and increased lipid peroxidation.  The harmful vascular effects 
of nicotine were further underscored by reduced intracellular NO levels and reduced cell 
viability in AECs.  Nicotine and rooibos co-treatment: RF exerted anti-contractile and pro-
relaxation responses in aortic rings and increased SOD and CAT activity (liver) in nicotine-
treated animals.  RF pre-treatment led to increased intracellular NO levels in nicotine-treated 
AECs.  Unfermented rooibos (RUF) exerted anti-contractile responses in aortic rings and 
increased CAT activity (heart) in nicotine-treated animals.  Nicotine and melatonin co-
treatments: Melatonin reduced blood pressure, exerted anti-contractile and pro-relaxation 
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responses in aortic rings, increased SOD activity (heart) and CAT activity (heart and liver), as 
well as decreased lipid peroxidation in nicotine-treated animals. 
Conclusion: Nicotine administration resulted in significant vascular and endothelial injury, 
associated with increased oxidative stress and reduced antioxidant activity.  Overall, our data 
showed that rooibos, specifically RF, and melatonin exerted beneficial effects on the vascular 
and endothelial system of nicotine exposed rats.  Mechanisms identified in this dissertation 
included their antioxidant properties, although other mechanisms cannot be ruled out. 
Restoration of vascular homeostasis, underscored by eNOS activation and subsequent 
release of NO, could underlie the modulating actions of both rooibos and melatonin.   
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OPSOMMING 
Inleiding en doelwitte: Sigaretrook is ‘n belangrike risikofaktor vir kardiovaskulêre siekte, en 
nikotien, die verslawende substans in tabak, word met die patogenese van aterosklerose via 
oksidatiewe stres, geassosieer.  Oksidatiewe stres kan lei tot ‘n verlies aan vaskulêre 
homeostase via verlaagde stikstofoksied (NO) biobeskikbaarheid, wat tot endodeeldisfunksie 
aanleiding kan gee.  Endoteeldisfunksie is ‘n vroeë, omkeerbare voorloper van aterosklerose 
en kardiovaskulêre siekte.  Die doel van hierdie proefskrif was om te bepaal of behandeling 
met die inheemse Suid-Afrikaanse plant, rooibos (gefermenteer of ongefermenteer) en die 
hormoon, melatonien, die skadelike effekte van nikotien op die vaskulêre en endoteel stelsels 
kan teenwerk. 
Metodes: Daar is van ‘n in vivo model (manlike Wistar rotte) en ex vivo model (aorta ring 
segmente) gebruik gemaak, sowel as ‘n in vitro model van rot aorta endoteelselle (AECs).  
Biometriese data, vloeistof inname, bloeddruk, vaskulêre funksie, antioksidant/oksidatiewe 
stres status, inflammatoriese merkers en serum lipiede is gemeet as eindpunte van die effekte 
van nikotien (5 mg/kg liggaamsgewig/dag; subkutaan toegedien) in die rot model.  Die gevolge 
van gesamentlike toediening van nikotien en rooibos (2% toegedien in drinkwater) en nikotien 
en melatonien (4 mg/kg liggaamsgewig/dag; toegedien in drinkwater) was vervolgens gemeet 
om te bepaal of die nikotien-geïnduseerde effekte teengewerk kon word.  Die modulerende 
effekte van gefermenteerde rooibos (RF) is verder ondersoek in ‘n in vitro model van AECs.  
Nikotien besering (100 µM oor 24 uur) is deur middel van intrasellulêre NO-produksie en 
sellewensvatbaarheid metings bepaal.  Die gevolge van nikotien, vooraf behandel met RF 
(0.015 mg/ml) is beoordeel volgens dieselfde eindpunte. 
Resultate: Nikotien-geïnduseerde vaskulêre besering:  Nikotientoediening (ses weke) het ‘n 
beduidende uitwerking op biometriese eindpunte gehad, vloeistof inname verminder, 
bloeddruk verhoog en ‘n pro-kontraktiele respons in aorta ringe ontlok.  Nikotientoediening het 
ook superoksied dismutase (SOD) en katalase (CAT) aktiwiteit (hart en lewer) verlaag, en 
lipiedperoksidasie verhoog.  Die skadelike vaskulêre effekte van nikotien is bevestig deur die 
waarneming van verlaagde intrasellulêre NO-vlakke en sellewensvatbaarheid in nikotien-
behandelde AECs.  Gesamentlike nikotien en rooibos toediening: RF het anti-kontraktiele en 
pro-dilaterende effekte in aorta ringe, asook verhoogde SOD en CAT aktiwiteit (lewer) in 
nikotien-behandelde diere tot gevolg gehad.  Vooraf behandeling met RF het gelei tot 
verhoogde intrasellulêre NO-vlakke in nikotien-behandelde AECs.  Ongefermenteerde rooibos 
(RUF) het anti-kontraktiele effekte in aorta ringe en verhoogde CAT aktiwiteit (hart) in nikotien-
behandelde diere tot gevolg gehad.  Gesamentlike nikotien en melatonien toediening: 
Melatonien het bloeddruk verlaag, anti-kontraktiele en pro-dilaterende effekte in aorta ringe, 
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verhoogde SOD aktiwiteit (hart) en CAT aktiwiteit (hart en lewer), asook verlaagde lipied 
peroksidasie in nikotien-behandelde diere tot gevolg gehad. 
Gevolgtrekkings: Nikotientoediening het beduidende vaskulêre en endoteel skade 
veroorsaak, wat met verhoogde oksidatiewe stres en verlaagde anti-oksidant aktiwiteit 
gepaard gegaan het.  Oor die algemeen toon ons resultate dat rooibos, spesifiek RF, en 
melatonien voordelige effekte op die vaskulêre en endoteel sisteme van nikotien-behandelde 
rotte gehad het. Die proefskrif het anti-oksidant aktiwiteit as ‘n moontlike meganisme 
geïdentifiseer wat hierdie effekte kan verklaar, alhoewel ander meganismes nie uitgesluit kan 
word nie.  Die herstel van vaskulêre homeostase, weens eNOS aktivering en daaropvolgende 
vrystelling van NO, kan verder onderliggend tot die beskermende aksies van beide rooibos en 
melatonien wees. 
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1.1. Introduction 
In 2011 the World Health Organisation (WHO) reported non-communicable diseases (NCD) 
to be the leading cause of death worldwide, with cardiovascular disease (CVD) being the 
leading cause of death amongst NCD (Fig 1.1) (Mendis, 2011).  It is expected that 
cardiovascular deaths will escalate to 23.4 million by the year 2030 (World Health 
Organization, 2009).  According to the Global Burden of Disease (GBD) 2010 report, CVD was 
responsible for 30% of all-age deaths globally, and for 9% of deaths in sub-Saharan Africa 
(GBD 2010).  In addition, cardiovascular mortality in South Africa is on the rise, specifically in 
the working age group (35 – 64 years), which can lead to a negative impact on the economy 
of the country (Steyn, 2007).  Cigarette smoking is one of the most important risk factors of 
CVD.  Smoking is responsible for 12% (6.2 million) of all deaths globally (Fig 1.2) (GBD 
2010), and for 12% of deaths in men and 4% of deaths in women in South Africa (Groenewald 
et al., 2007).  It is estimated that over five million people are current or ex tobacco users and 
that over 600,000 non-smokers die from the exposure to second hand smoke (World Health 
Organization, 2011).  Nicotine, the addictive substance in tobacco, is implicated in the 
pathogenesis of atherosclerosis, an important precursor of CVD (Tsiara et al., 2003 and Kilaru 
et al., 2001).   
 
 
Figure 1.1.  Distribution of global NCD by cause of death in persons less than 70 years old.  
(Mendis, 2011). 
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Figure 1.2. Smoking is responsible for ~12% (6.2 million) of all deaths globally (GBD, 2010). 
 
1.2. The Vascular Endothelium and Endothelial Dysfunction 
1.2.1. The Vascular Endothelium: Structure and Function 
The endothelium is a thin, continuous layer of endothelial cells (ECs) that line the interior of 
all blood vessels and can be considered an active and dynamic tissue (Fig 1.3) (Gonzalez and 
Selwyn, 2003).  ECs are flat with a large nucleus that often protrudes into the vascular lumen.  
The appearance of ECs varies according to their location, being spindle-shaped in arteries 
and arterioles and oriented in the direction of the blood flow, whereas in capillaries and venules 
ECs are of a more rounded shape (Mas, 2009).  The endothelium consists of approximately 
ten trillion (1013) cells and weighs almost one kg in an adult (Galley and Webster, 2004).  
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Figure 1.3.  A normal large artery, consisting of three distinct layers; the intima, the media and 
adventitia.  (Lusis, 2000) 
 
ECs have a prominent Golgi apparatus, which suggests a significant secretory activity (Mas, 
2009).  Even though ECs have abundant mitochondria, most of their energy is supplied 
through anaerobic glycolysis, showing low oxygen consumption (Davidson and Duchen, 
2007).  ECs are attached to each other by zipper-like junctions along the cell borders and 
linked to networks of cytoskeletal and signalling proteins.  Three types of junction structures 
have been identified: adherens junctions, tight junctions and gap junctions (Dejana, 2004).  
The luminal surface of the endothelium is covered with a negatively charged mesh-like 
structure made up of glycoproteins and proteoglycans, anchored to ECs by transmembrane 
protein domains.  This structure is known as the endothelial glycocalix and has an estimated 
thickness of 50-100 nm (Rutledge et al., 2010) (Fig 1.4). 
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Figure 1.4. Electron microscopy image of the endothelial glycocalyx.  Bar = 200 nm.  
(Rutledge et al, 2010) 
 
The endothelium is involved in a number of important functions, such as maintenance of blood 
circulation and regulation of vascular tone, as well as synthesizing and releasing vasoactive 
substances, thus playing an important role in maintaining vascular homeostasis (Behrendt and 
Ganz, 2002). 
 
1.2.2. Endothelium-Derived Vasoactive Factors 
The endothelium maintains vascular homeostasis by releasing a variety of vasoactive factors.  
These factors can cause either dilation or constriction of the blood vessels, depending on the 
type of stimulus (Chhabra, 2009).  Under normal circumstances vasodilator signals 
predominate compared to vasoconstrictor signals, but the delicate balance between these 
factors can be reversed by cardiovascular risk factors (Mas, 2009).  Vasodilatory agents 
include nitric oxide (NO), prostacyclin (PGI2) and endothelium-derived hyperpolarising factor 
(EDHF) (Table 1.1) (Mudau et al., 2012).  Vasoactive factors responsible for vasoconstriction 
include endothelin-1 (ET-1), thromboxane A (TXA2) and angiotensin II.   
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Table 1.1. Overview of endothelium-derived vasoactive factors. (Mudau et al., 2012) 
An Overview of Endothelium-derived Vasoactive Factors 
Endothelium-
derived factors 
Physiological effects Enzymatic source and mechanism of 
action 
Nitric Oxide (NO) - Potent vasodilator 
- Inhibits inflammation, 
vascular smooth muscle 
cells (VSMCs) 
proliferation and 
migration, platelet 
aggregation and adhesion 
and leukocyte adhesion 
- Regulates myocardial 
contractility  
- Regulates cardiac 
metabolism 
- Cardio-protective during 
ischaemia-reperfusion 
injury 
- Synthesized by the enzymes, eNOS, nNOS 
and iNOS, with eNOS being the major 
source of NO during physiological conditions 
- Diffuses from ECs to underlying VSMCs 
where it binds to soluble guanylyl cyclase 
(sGC), leading to a cascade of events that 
ultimately result in vascular relaxation 
Prostacyclin (PGI2) - Vasodilatory agent 
- Inhibits platelet 
aggregation 
- Derived from arachidonic acid by 
cyclooxygenase-2 (COX-2) 
Endothelium-
derived 
hyperpolarizing 
factor (EDHF) 
- Exerts vasodilatory 
effects, particularly in 
small arteries of diameter 
≤ 300 µm 
- Its identity is still under suspicion with 
proposed candidates such as potassium 
ions and hydrogen peroxide 
Endothelin-1 (ET-1) - A potent vasoconstrictor - Synthesized by endothelin-converting 
enzyme 
- Exerts its effects via two receptors: ETA 
expressed on ECs and ET8 on VSMCs.  ETA 
receptors promote vasoconstriction, whereas 
ET8 receptors promote NO production and 
ultimately reduction in ET-1 production 
Thromboxane A 
(TXA2) 
- A potent vasoconstrictor - Derived from arachidonic acid by COX-1 
Angiotensin II (Ang 
II) 
- A potent vasoconstrictor - Synthesized by angiotensin converting 
enzyme 
- Elicits its effects via two receptors: AT1 
which promotes vasoconstriction and cell 
proliferation, and AT2 which antagonizes the 
effects of AT1 
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1.2.2.1. Nitric Oxide 
It is only relatively recently that the role of NO as an important endogenous signalling molecule 
has come to the forefront (Neill et al., 2008).  Until the discovery in 1987 that the previously 
unidentified molecule, only termed ‘endothelium-derived relaxing factor’ (EDRF) was in fact 
NO, the molecule was thought of merely as a toxic by-product of combustion (Ignarro et al., 
1987).  NO is a simple diatomic gas and free radical, properties that allow for easy passage 
between cells and tissues, while being able to react with a large number of molecules.  These 
properties make NO an ideal signalling molecule, capable of a wide range of biological effects 
(Strijdom et al., 2009).  NO is considered to be the most potent endogenously synthesized 
vasodilator in the body, and the pathophysiological consequences of reduced NO 
bioavailability is a key marker of endothelial dysfunction (Mudau et al., 2012). 
NO is generated by nitric oxide synthases (NOS), of which three distinct isoforms exist, namely 
neuronal (nNOS), inducible (iNOS) and endothelial NOS (eNOS) (Naseem, 2005).  Both 
eNOS and nNOS are constitutive, calcium-dependent enzymes that continuously produce low 
levels of NO and studies in gene disrupted mice indicate that both nNOS and eNOS have anti-
atherosclerotic actions (Liu and Huang, 2008).  eNOS is constitutively expressed in the 
endothelium, following activation by acetylcholine or bradykinin, as well as by the shear stress 
of flowing blood (Li et al., 2014).  However, iNOS is calcium independent and its expression 
provoked by inflammatory cytokines.  This leads to the production of large amounts of NO, up 
to a 1000-fold more than eNOS or nNOS.  The excess NO can react with the free radical 
superoxide anion (O2•-) and yield highly reactive species, peroxynitrite (Strijdom et al., 2009).  
All NOSs require cofactors, such as (6R)-5,6,7,8-tetrahydrobiopterin (BH4), flavin adenine 
dinucleotide (FAD), flavin mononucleotide (FMN) and iron protoporphyrin IX (haem) (Alderton 
et al., 2001).   
It has been proposed that, of the three isoforms, eNOS is responsible for NO production under 
physiological conditions in the cardiovascular system, specifically in ECs.  The production of 
NO by eNOS leads to the classical signalling mechanism in the underlying vascular smooth 
muscle cells (VSMCs) which, in turn, leads to relaxation (Dudzinski and Michel, 2007).   
Absence of some of the cofactors mentioned above or the failure of the eNOS protein to 
dimerise, will lead to the enzyme catalysing the formation of O2•- instead of NO, a mechanism 
referred to as eNOS uncoupling (Föstermann and Munzel, 2006). 
It has been proposed that the release of endothelial derived NO can prevent leukocyte 
adhesion and subsequent migration into the subendothelial space (Kubes et al., 1991).  NO 
can also down regulate gene expression of adhesive proteins and inhibit LDL oxidation by 
reacting with lipid peroxyl radicals (Rubbo et al., 1994).  NO is responsible for protecting the 
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vascular wall by inhibiting the actions of serotonin and thromboxane A2, which are platelet-
derived vasoconstrictive factors (Michel and Vanhoutte, 2010).  In addition to supressing 
platelet aggregation, NO prevents endothelial cell apoptosis and inhibits VSMC proliferation 
and migration (Lei et al., 2013). 
 
1.2.2.2. Endothelial Dysfunction 
Endothelial dysfunction (ED) can occur when the balance between a vasodilatory and 
vasoconstrictory state is disrupted, resulting in ECs losing their ability to maintain 
homeostasis, ultimately leading to impairment of vasorelaxation, as well as increased 
adhesiveness of the endothelium for circulating inflammatory cells (Gonzalez and Selwyn, 
2003).  Even though the pathogenesis of ED is considered multifactorial, oxidative stress 
appears to be a common underlying cellular mechanism (Mudau et al., 2012).  Oxidative stress 
can lead to the imbalance of endothelium-derived vasodilatory and vasoconstrictory factors, 
whereby the pro-vasoconstrictory states become dominant, leading to progressive 
pathophysiological changes.  These endothelial changes can promote vascular adhesion, 
coagulation and proliferation and exhibit pro-inflammatory and pro-oxidant features (Chhabra, 
2009).  ED is an early precursor of atherosclerosis and is associated with a number of 
cardiovascular risk factors, including hypertension, diabetes and smoking (Cipollone et al., 
2007).  It has been shown that early endothelial changes, such as ED, are reversible (Hsueh 
et al., 2004) which has great clinical relevance in terms of early diagnosis, stratification and 
potential treatment of CVD.  However, if risk factors are sustained and early endothelial 
changes not reversed progression to atherosclerosis and subsequent CVD will follow (Fig 1.5) 
(Mudau et al., 2012). 
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Figure 1.5.  Exposure of endothelial cells to cardiovascular risk factors and the resultant 
pathophysiological changes.  Adapted from Mudau et al., 2012. 
 
1.3. Atherosclerosis 
Atherosclerosis is a chronic inflammatory disease, which is characterised by the hardening 
and thickening of the blood vessels via the formation of an atherosclerotic plaque or lesion 
(atheroma), which can lead to vascular occlusion and limited blood flow.  Atherosclerosis is 
associated with ischaemic heart disease, stroke and a number of other CVD conditions 
(Cipollone et al., 2007 and Fearon and Faux, 2009).  ED is considered the first phase in the 
development of the atherosclerotic plaque and is followed by the inflammatory phase, the 
reparative phase and finally, the thrombotic phase (Naseem, 2005).   
Cholesterol in the blood, specifically low-density lipoprotein-cholesterol (LDL-cholesterol) is 
able to passively diffuse into the arterial wall.  LDL becomes trapped through the interaction 
between apolipoprotein B100 and matrix proteoglycans and is subject to oxidative modification 
due to prolonged exposure to reactive oxygen species (ROS) and reactive nitrogen species 
(RNS).  Oxidised LDL (OxLDL) is able to exert a pro-inflammatory response to produce 
chemokines, such as monocyte chemotactic protein-1, as well as growth factors.  Adhesion 
molecules, such as P-selectin and vascular adhesion molecule-1 (VCAM-1) are also 
expressed.  Through this process monocytes are recruited and their entry facilitated and 
differentiation into macrophages stimulated.  As macrophages take up oxLDL through 
scavenger receptors, lipid laden foam cells are formed (Fig 1.6) (Lusis, 2000). 
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The fibrous cap found on atherosclerotic plaques is a result of macrophages secreting growth 
factors and cytokines, which in turn promote migration and proliferation of VSMCs and secrete 
excess extracellular matrix proteins (Naseem, 2005).  When foam cells die, a lipid-rich necrotic 
core, enclosed by a fibrous cap is left behind.  These plaques can become more complex 
through calcification and haemorrhage, resulting from small blood vessels that grow into the 
lesion.  The advanced plaques can grow large enough to block blood flow or rupture, leading 
to thrombosis, which usually results in myocardial infarction or stroke (Fig 1.7) (Lusis, 2000). 
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Figure 1.6. The first two phases in the development of the atherosclerotic plaque: (A) 
endothelial dysfunction; (B) inflammatory phase. (Naseem, 2005) 
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Figure 1.7. The advancement of atherosclerosis: (C) reparative fibrotic phase; (D) thrombotic 
phase.  (Naseem, 2005) 
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1.3.1. Vascular Oxidative Stress 
The role of oxidative stress in the development of CVD has been recognized for many years, 
while studies indicate that altered oxygen utilization and an increase in ROS levels contribute 
to the progression of CVD (Wattanapitayakul and Bauer, 2001).   The role of ROS in 
physiological signalling has been elucidated more recently and evidence indicates that 
signalling pathways modulated by ROS are complex and compartmentalized (Brown and 
Griendling, 2015).  ROS reduce and eliminate the protective abilities of NO, which in turn will 
lead to endothelial dysfunction (Barua et al., 2003).  Experimental and clinical data indicate 
that exposure to harmful substances such as nicotine increases oxidative stress and has the 
potential to induce endothelial dysfunction (Ambrose and Barua, 2004).   
ROS include superoxide (O2•-), hydrogen peroxide (H2O2), peroxynitrite (OONO-) and the 
hydroxyl radical (HO•), all of which are reactive molecules containing oxygen.  ROS are 
constantly produced in biological systems and several endogenous defence mechanisms 
have been identified, including enzymes such as superoxide dismutase (SOD), which 
removes superoxide radicals by catalysing a dismutation reaction to hydrogen peroxide and 
oxygen (Ceconi et al., 2003) and catalase, which accelerates the decomposition of hydrogen 
peroxide to oxygen and water (Li et al., 2014).  Glutathione peroxidase (GPx) is able to reduce 
hydrogen peroxide to water and lipid hydroperoxidases to alcohols (Lubos et al., 2011).  Lipid 
peroxidation presents a further mechanism of cellular injury and is often used as an indicator 
of oxidative stress in cells (Yagi, 1998).  Lipid peroxidases are derived from polyunsaturated 
fatty acids and are unstable.  These unstable compounds decompose to form reactive 
carbonyl compounds such as malondialdehyde (MDA) (Wang et al., 2001).  An increase in 
ROS as a result of various cardiovascular risk factors, such as hypertension, diabetes and 
smoking not only contributes to the development of atherosclerosis, but can also lead to a 
reduction in eNOS derived NO and its vasculature protective properties (Fig 1.8) (Li et al., 
2014). 
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Figure 1.8. The role of oxidative stress in the progression of atherosclerosis, whereby ROS-
producing enzymes are activated and/or ROS-detoxifying systems are affected by 
cardiovascular risk factors. (Li et al., 2014.) 
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1.4. Nicotine  
1.4.1. Nicotine Chemistry and Metabolism 
Nicotine (3-[(2S)-1-Methyl-2-pyrrolidinyl]pyridine) is an alkaloid substance found in tobacco 
leaves where it naturally acts as a botanical insecticide (Fig 1.9).  Nicotine comprises 
approximately 95% of the total alkaloid content of cigarette tobacco with about 1 – 1.5 mg of 
nicotine being absorbed systemically during smoking (Benowitz and Jacob, 1984).  When 
smoking a cigarette, nicotine is distilled from tobacco and carried into the lungs by smoke 
particles and absorbed into the pulmonary venous circulation and then enters the arterial 
circulation.  Peak arterial concentrations of nicotine can be reached within 20-30 seconds of 
inhalation.  Nicotine then moves rapidly from the lungs to the brain, where it is able to bind to 
nicotinic acetylcholine receptors (nAChRs) (Rose et al., 1999).   
 
a   b  
Figure 1.9. The 2D (a) and 3D (b) structure of nicotine. 
 
nAChRs are ligand-gated ion channels present in both the peripheral nervous system (PNS) 
and the central nervous system (CNS).  nAChRs respond to high and low doses of 
acetylcholine (ACh), as well as to systemically applied pharmacological agents, such as 
nicotine.   Binding of nicotine results in the assembly of principal (α2, α3, α4, α6) and 
complementary (β2, β4) subunits, with the highly expressed α4β2 receptors displaying the 
highest level of upregulation (Nguyen et al., 2004).  The activation of brain nAChRs result in 
the release of various neurotransmitters, including dopamine, serotonin, glutamate and GABA 
(γ-aminobutyric acid) (Taly et al., 2009).  Nicotine primarily acts on the central nervous system 
by initiating action potentials in dopaminergic neurons when binding to nAChRs on the cell 
bodies in the ventral tegmental area (VTA).  The release of dopamine gives nicotine its 
rewarding properties and is integral to its addictive nature (McRobbie and Thornley, 2008).  
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Dopamine is released in the mesolimbic area, the corpus striatum and frontal cortex.  
Dopaminergic neurons in the VTA, as well as in the shell of the nucleus accumbens are critical 
in drug-induced reward and play a role in the perceptions of pleasure and reward (Fig 1.10) 
(Benowitz, 2010).  After absorption and entering the bloodstream nicotine is distributed to body 
tissues, with a high affinity for the liver, kidney, spleen and lung.  Nicotine binds to brain tissues 
with high affinity and, over time, the receptor binding capacity in smokers is increased, 
compared to non-smokers.  This is caused by an increase in the number of nicotine cholinergic 
receptors in the brain of smokers (Perry et al., 1999).  Nicotine is metabolised by the liver and 
six primary metabolites have been identified, the most important and abundant being a lactam 
derivative, cotinine (Benowitz, 2010). 
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Figure 1.10. The role of the mesolimbic dopamine system in nicotine activity, whereby nicotine 
activates nACh receptors in the VTA.  The result is a release of dopamine in the shell of the 
nucleus accumbens.  Sketch taken from Benowitz, 2010. 
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1.4.2. Nicotinic Acetylcholine Receptors (nAChRs) in the Vasculature 
In addition to the nervous system, nAChRs are expressed ubiquitously in many cell types, 
including ECs and VSMCs (Lindstrom, 1997).  The structure of vascular nAChRs closely 
resembles that of nAChRs in the CNS, namely a pentamer composed of distinct subunits, 
arranged tightly around a central pore (Egleton et al., 2009).  In humans, 16 isoforms of 
subunits have been identified, including α subunits (α1-α10), β subunits (β1-β4), γ, δ and ε 
subunits (Gotti et al., 2007).  While ACh is the endogenous ligand for nAChRs, nicotine has 
also been shown to be a high-affinity vascular nAChR ligand.  Ligand binding leads to 
conformational changes in the nAChR, resulting in opening of the ion channel and 
transmission of signals (Santanam et al., 2012).  Binding of nicotine to vascular nAChRs are 
capable of exerting direct action on multiple cell types in the cardiovascular system.  Cell types 
include VSMCs, endothelial cells, platelets and other cellular effectors of importance in the 
formation of the atherosclerotic plaque (Egleton et al., 2009).  It has also been shown that 
several components of atherogenesis, including inflammation, proliferation and migration are 
regulated through non-neural nicotinic cholinergic pathways (Bauwens et al., 2015).  Nicotine 
stimulates nAChR mediated VSMC migration via important signalling pathways, including 
increased calcium influx, activation of epidermal growth factor receptor (EGFR) and 
phosphorylation of Ets-like gene 1 (Kanda and Watanabe, 2007; Vazquez-Padron et al., 
2010).   
The α7 nAChR subunit is of particular interest in the development of atherosclerosis, since it 
is found in non-neural cells, such as macrophages (Wang et al., 2003) and has also been 
detected in rat arterial systems (Bruggmann et al., 2002).  It has been demonstrated that, while 
ECs express most of the known mammalian nAChR subunits, the effects of nicotine are largely 
mediated through the α7 nAChR, while the other subunits play a modulatory role (Wu et al., 
2009).  Furthermore, studies have shown that the α7 nAChR plays a critical role in EC 
proliferation, survival, migration and tube formation (Heeshen et al., 2002).  These findings 
are further substantiated by studies indicating that α-bungarotoxin, a selective antagonist of 
homomeric nAChRs and the neuromuscular nAChR, can inhibit nicotine-induced EC 
angiogenic processes (Ng et al., 2007).  These mechanisms mediated by nAChRs, specifically 
α7 nAChR, may contribute to the pathological neovascularization associated with nicotine use, 
and could have therapeutic relevance (Wu et al., 2009).   
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1.4.3. Nicotine and Atherosclerosis 
Nicotine is associated with the development of several diseases, including CVD, emphysema 
and cancer, all of which present abnormal neovascularization as a common feature (Costa 
and Soares, 2009).  Nicotine exerts significant cardiovascular effects, such as an increase in 
heart rate and myocardial contractility, as well as an increase in myocardial uptake and 
oxidation of free fatty acids.  A summary of the cardiovascular effects of nicotine are given in 
Table 1.2 (Kilaru et al., 2001).  It has been shown that coronary blood flow has a biphasic 
response to nicotine.  Initially nicotine intake increases blood flow in the large coronary vessels 
and smaller resistance vessels, after which there is a decrease in blood flow.  The decrease 
in blood flow is mediated by alpha-adrenergic vasoconstriction of coronary resistance vessels 
(Kaijser and Berglund, 1985).  Nicotine increases blood pressure and may contribute to the 
acceleration of hypertension by its pro-vasoconstriction effects, as well as promoting 
interactions between platelets and the endothelial cell lining (Downey et al., 1981).  It has also 
been shown that nicotine is able to affect lipid metabolism by increasing LDL-cholesterol and 
decreasing high-density lipoprotein (HDL) cholesterol, while resulting in higher levels of 
OxLDL (Clutte-Brown et al., 1986; Harats et al., 1989).  Nicotine users exhibit decreased NO 
bioavailability and impaired flow-mediated vasodilation, characteristics which are highly 
suggestive of ED (Puranik and Celermajer, 2003). 
 
Table 1.2. Cardiovascular effects of nicotine (Kilaru et al., 2001). 
Increase in heart rate and myocardial contractility 
Increase in cardiac output, stroke volume, and coronary blood flow 
Cutaneous vasoconstriction 
Subcutaneous vasoconstriction 
Coronary vasoconstriction 
Increase in muscle blood flow 
Hyperlipidaemia: increased LDL-cholesterol, decreased HDL-
cholesterol 
Endothelial injury 
Platelet activation and thrombosis 
Increased levels of fibrinogen 
Increased circulating catecholamines 
Intimal hyperplasia 
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Nicotine has been shown to be a pro-angiogenic factor, whereby new blood vessels can 
develop from pre-existing ones.  Angiogenesis is a dynamic process regulated by the balance 
between angiogenic activating and inhibiting factors (Costa et al., 2007).  Angiogenesis relies 
on various changes to the matured vessel, including pericyte detachment, extracellular matrix 
(ECM) degradation and remodelling, followed by proliferation, migration and assembly of ECs 
into tubule structures (Costa et al., 2007).  The proliferation, migration and adhesion of SMCs 
are also associated with angiogenesis (Fam et al., 2003).  While angiogenesis plays an 
important role in many physiological situations, such as ovulation, embryogenesis and 
placental development, excess angiogenesis can lead to a variety of pathological situations, 
such as atherosclerotic plaque development, diabetic retinopathy and cancer (Pandya et al., 
2006).  Genetic predisposition has also been suggested to influence the development of 
atherogenesis in individuals exposed to nicotine, however the importance of genetic variants 
remain unknown.  It has been proposed that either CYP1A1 MSP polymorphism or certain 
eNOS intron 4 polymorphisms increase susceptibility to nicotine exposure related 
atherosclerosis development (Wang et al., 2002).  
Inflammation associated with nicotine intake has been suggested to be an essential 
component in the initiation and evolution of atherosclerosis.  Cigarette smoking causes an 
increased level of multiple inflammatory markers, including C-reactive protein (CRP), 
interleukin-6 (IL-6) and tumour necrosis factor alpha (TNF-α) (Ambrose and Barua, 2004) and 
nicotine has been shown to significantly affect CRP, IL-6 and TNF-α levels in newborn rats 
after prenatal nicotine-exposure (Mohsenzadeh et al., 2014).  Interest in the relevance of these 
circulating inflammatory biomarkers to coronary heart disease has increased greatly since the 
link between inflammation and atherosclerosis became known (Danesh et al., 2008).   
CRP, a phylogenetically highly conserved plasma protein, is a liver-derived inflammatory 
biomarker which participates in the systemic response to inflammation and is considered part 
of the acute phase inflammatory response (Black et al., 2004).  CRP induction is primarily 
regulated at the transcriptional level by IL-6, the effect of which can be enhanced by 
interleukin-1β (IL-1β) (Kushner et al., 1995).  IL-6 has been shown to play a central part in the 
downstream inflammatory response responsible for atherosclerosis and is essential in the 
initiation and progression of the atherosclerotic lesion (Hartman and Frishman, 2014).  
According to various worldwide studies, CRP predicts future risk for CVD in apparently healthy 
individuals, including myocardial infarction, coronary artery disease, stroke and peripheral 
arterial disease (Ridker, 2003).  In addition, the presence of CRP mRNA and proteins have 
been demonstrated in human atherosclerotic lesions and vascular cells (Calabro et al., 2003; 
Dong and Wright, 1996), futher underscoring the importance of CRP as an inflammatory 
biomarker for atherosclerosis. 
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TNF-α is considered one of the most important inflammatory cytokines, playing a crucial role 
in innate and adaptive immunity, cell proliferation and apoptotic processes (Pober et al., 2006).  
There is evidence to suggest that TNF-α impairs endothelium-dependent and NO-mediated 
vasodilation in vascular beds (Gao et al., 2007; Picchi et al., 2006), possibly via down 
regulation of eNOS activation and expression, thereby reducing or diminishing NO production 
(Goodwin et al., 2007; Picchi et al., 2006).  The involvement of TNF-α in the induction of ED 
and the initiation of atherosclerosis is further supported by the beneficial effects of anti-TNF-α 
agents on endothelial function in patients with chronic inflammatory diseases (Cardillo et al., 
2006; Bilsborough et al., 2006).  Elevation of these inflammatory cytokines in turn leads to the 
local recruitment of leukocytes on the surface of ECs, which is an early event in 
atherosclerosis (Bermudez et al., 2002).  CRP, IL-6 and TNF-α have recently been used to 
demonstrate the association between smoking quantity and inflammation, leading to 
hypertension (Feng et al., 2013).  As such, CRP, IL-6 and TNF-α are useful markers of 
inflammation associated with nicotine exposure and the initiation and progression of 
atherosclerosis. 
 
1.4.4. Nicotine Addiction and Therapy 
The potentially harmful effects of tobacco use has only been proven reasonably recently.  
However, the, captivating influence of tobacco was known by the Native Americans and this 
concept quickly spread to the Europeans.  Francis Bacon, the English philosopher wrote the 
following on the spread of tobacco:  
‘In our time the use of tobacco is growing greatly and conquers men with a certain 
secret pleasure, so that those who have once become accustomed thereto can later hardly 
be restrained therefrom.’ (Francis Bacon, Historia vitae et mortis, 1623) 
 
The truly addictive nature of nicotine has only been accepted by the scientific community 
reasonably recently, since tobacco smoking was originally seen as merely a habit (Russell, 
1971).  The importance of deciphering the mechanisms of nicotine addiction became more 
important as the link between tobacco smoking and certain diseases, such as lung cancer, 
became more evident (Dani and Balfour, 2011).  Nicotine addiction is extremely complex and 
smokers rely on cigarettes to induce pleasure, reduce stress and improve concentration, while 
relief from withdrawal symptoms directly enhance mood and performance.  Withdrawal 
symptoms can be severe and include depressed mood and anxiety, as well as anhedonia 
(feeling that there is little pleasure in life) can also occur (Hughes, 2006). 
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By the 1980s, the nicotine dependence hypothesis and the withdrawal effects associated with 
smoking cessation had been accepted.  Along with this the importance of using nicotine 
replacement therapy (NRT) to aid cessation became prominent (Dani and Balfour, 2011).  The 
most popular forms of NRT include transdermal nicotine patches and nicotine gum, while the 
recent invention and popularization of electronic cigarettes (e-cigarettes) provide a further 
possibility for such treatments.  While it seems unlikely that nicotine, which is directly 
implicated in the onset and acceleration of atherosclerosis and, in turn, CVD should be used 
to assist with smoking cessation, it remains popular and effective (Elam, 2015).  It is important 
to note that cigarette smoke is a complex mixture of substances, some of which are potentially 
cardiotoxic, such as carbon monoxide.  In addition to eliminating carbon monoxide, a 
hypercoagulable and thrombosis promoting state is also not found when NRT is used, possibly 
due to lower levels of circulating epinephrine.  Increased heart rate and blood pressure, which 
in turn increases myocardial work is also reduced with the use of NRT (Benowitz and Gourlay, 
1997).   
Studies examining the effect of NRT on cardiovascular parameters have produced conflicting 
results (Vansickel et al., 2010; Farsalinos et al., 2014).  Some studies have shown increases 
in heart rate and blood pressure following NRT use (Fishbein et al., 2010; Yugar-Toledo et al., 
2005; Najem et al., 2006), while other studies showed no effect (Blann et al., 1997; Tanus-
Santos et al., 2001) on these parameters.  It has been suggested that these discordant 
findings could be due to smokers, particularly heavy smokers, developing tolerance to the 
pressor effects of nicotine, resulting in hemodynamic markers being unaffected (Tanus-Santos 
et al., 2000).  Interest in the safety of NRT in patients, specifically with those CVD, has led to 
the development of large clinical trials.  In a five week, randomized, double-blind trial patients 
with coronary disease who smoked at least one pack per day received either nicotine patches 
or placebo in addition to weekly counselling sessions.  Despite there being no differences in 
the frequencies of angina or arrhythmias between the groups, the use of NRT led to more 
frequent cessation of smoking in these groups (Working Group for the Study of Transdermal 
Nicotine in Patients with Coronary Artery Disease, 1994).  Similar trends have been seen in 
recent studies, where nicotine patch users and non-users showed no difference in 7-day, 30-
day or 1-year mortality after unstable angina (Meine et al., 2005).  In a database study of 663 
smokers, following the first year after an acute coronary event, no association was found 
between NRT and risk of adverse cardiovascular events (Woolf et al., 2012). 
Based on pharmacologic mechanisms, NRT could cause deleterious cardiovascular effects, 
however, clinical studies are as yet, inconclusive and have been suggested to be 
underpowered to sufficiently demonstrate the potential risks.  Despite inconclusive evidence 
of the safety of NRT, these treatments are associated with improved smoking cessation rates, 
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making them clinically appropriate to use in patients who wish to quit smoking (Sobieraj et al., 
2013).  Furthermore, it has been shown that consultations with a physician as well as 
participation in support groups and counselling sessions are extremely important if smoking 
cessation is to be successfully achieved (World Health Organization, 2015).  Until clinical 
studies yield more conclusive results as to the potential deleterious cardiovascular effects of 
NRT, it is worth considering the possible harmful effects of these treatments, including 
measures to modulate deleterious cardiovascular effects. 
 
1.5. Rooibos (Aspalathus linearis) 
Rooibos (Aspalathus linearis) is an indigenous South African herb, as well as a popular 
beverage and has long been known to possess biological properties (Fig 1.11) (Robak and 
Gryglewski, 1996).  Rooibos has potent antioxidant, immune-modulating and chemo-
protective actions, with the additional benefit of causing no adverse effects (McKay and 
Blumberg, 2007). In addition, it has been established that even though both unfermented and 
fermented rooibos are able to increase plasma antioxidant defences, unfermented rooibos has 
a higher antioxidant potency than fermented rooibos tea (Villaño et al., 2010).  In addition, it 
has been shown that consumption of fermented rooibos can improve the lipid profile and redox 
status, which is relevant in the development of CVD (Marnewick et al., 2011).          
 
a    b  
Figure 1.11. a) Rooibos growing on a farm in the Clanwilliam district of South Africa and b) 
dried rooibos leaves and tea bags.  Images obtained from the internet.  Websites: a) 
www.thedailytea.com and b) www.lauradutoit.hubpages.com.  
 
 
 
Stellenbosch University  https://scholar.sun.ac.za
 24 
 
1.5.1. Chemical Composition and Colour Formation of the Fermentation Process 
Health claims pertaining to the beneficial effects of rooibos are mostly based on the high 
polyphenol content of the species.  Rooibos boasts a unique flavonoid content and contains 
various dihydrochalcones, including aspalathin, a C-linked dihydrochalcone glucoside 
(Koeppen and Roux 1965, 1966, Rabe et al., 1994) and aspalalinin, a cyclic dihydrochalcone 
(Shimamura et al., 2006), which are both unique to Aspalathus linearis (Fig 1.12).  The 3-
dehydroxy dihydrochalcone, nothofagin, is also present, this rare compound has previously 
been shown to be present only in the heartwood of Nothofagus fusca (Hillis and Inoue, 1967).    
   
 
Figure 1.12.  Chemical structure of specific flavonoids present in rooibos, including the unique 
aspalathin and aspalalinin.  (Joubert et al., 2008)  
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The degradation of green rooibos to the characteristic red-brown fermented product is a result 
of the non-enzymatic oxidative degradation of aspalathin (Krafczyk et al., 2009).  It has been 
shown that the aspalathin content of rooibos can be reduced by as much as 98% during the 
fermentation process (Schulz et al., 2003).  Two mechanisms of degradation of aspalathin 
have been elucidated to date.  The first mechanism entails the oxidation of aspalathin to o-
quinone, which is then converted to isoorientin and and orientin via eriodictyol 
glucopyranosides (Krafczyk and Glomb, 2008).  Secondly, oxidation can initiate the 
dimerization of aspalathin.  During this process the o-quinone is attacked nucleophylically by 
a second aspalathin molecule (Krafczyk et al., 2009). 
In addition to two colourless dimers formed during initial oxidation (as described by Krafczyk 
et al in 2009), two further colourless substances are formed during continued oxidation, but 
later completely degraded.  Two coloured structures with dibenzofuran skeletons have also 
been identified and their importance as key chromophores in the chemistry of colour formation 
during fermentation demonstrated (Heinrich et al., 2012). 
 
1.5.2. Potential Health Benefits of Rooibos  
For a long period of time the health benefits of rooibos were merely anecdotal.  However, in 
vitro and in vivo studies have shown the potential treatment value of rooibos.  Both 
unfermented and fermented rooibos have been shown to increase plasma total antioxidant 
capacity in humans, thus underlying its potential modulating effects, even though it has been 
suggested that fermentation can reduce the protective effect of rooibos (Villaño et al., 2010 
and Marnewick et al., 2009). 
Rooibos is commonly used for treating diarrhoea and abdominal spasm.  The antispasmodic 
effects of rooibos have been demonstrated in isolated rabbit jejunum preparations.  It has 
been proposed that the antispasmodic effects of rooibos is mediated mainly through K+-
channel activation (Gilani et al., 2006).   
Since obesity and related metabolic diseases are on the increase globally (Guh et al., 2009), 
rooibos has also attracted attention as a potential safe and non-caloric intervention 
(Sanderson et al., 2014).  Studies in mice receiving an increased energy intake Western-type 
diet and aqueous rooibos extract intervention lead to significant reductions in serum 
cholesterol, triglyceride and free fatty acid concentrations.  The study suggested that the 
activation of AMP-activated protein kinase (AMPK), resulting in the regulation of energy 
homeostasis played a role in the effects of rooibos (Beltrán-Debón et al., 2011).   
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The cardioprotective properties of rooibos have also been demonstrated.  A six week trial in 
40 human volunteers, consuming six cups of fermented rooibos per day, resulted in a 
significantly improved lipid profile and redox status, when compared to controls, which is 
relevant to heart disease in adults at risk for developing CVD (Marnewick et al., 2011).  This 
is specifically relevant, since fermented rooibos is the traditional form in which the beverage 
is consumed.  A seven week treatment with rooibos offered cardioprotection against 
ischaemia/reperfusion in isolated perfused rat hearts.  Protection was attributed to the high 
flavonoid content of rooibos, resulting in a significantly decreased level of cleaved caspase-3 
and poly(ADP-ribose) polymerase (PARP), which are both pro-apoptotic proteins, as well as 
an improved GSH/GSSG ratio (Pantsi et al., 2011).  The cardioprotective effect of fermented 
rooibos has also been demonstrated on cultured cardiomyocytes derived from diabetic rats, 
whereby pretreatment with rooibos provided better protection than the known antioxidant 
vitamin E in a H2O2 or ischaemic injury model (Dludla et al., 2014).  A dose-dependent fall in 
arterial blood pressure has been shown in anaesthetized rats, where blood pressure was 
measured through carotid artery cannulation (Khan and Gilani, 2006).   
However, despite the promising results generated in the past few years, studies into the 
cardioprotective effects of rooibos, both fermented and unfermented, remain limited, with 
investigations into the effects of rooibos in the vascular endothelium lacking in particular. 
 
1.6. Melatonin 
1.6.1. Melatonin Synthesis, Secretion and Binding 
The hormone melatonin (N-acetyl-5-methoxytrypamine), a derivative of the essential amino 
acid tryptophan, was first isolated from the bovine pineal gland by Lerner et al (1958).  
Melatonin is a small molecule with highly lipophilic and hydrophilic properties, enabling it to 
cross biological barriers (Venegas et al., 2012) and is present in all bodily fluids, tissues and 
cellular compartments (Reiter et al., 2013).  The suprachiasmatic nucleus (SCN) is the central 
circadian pacemaker and controls the production of melatonin by triggering the pineal gland 
to produce melatonin at night (Fig 1.13).  The duration of release of melatonin is proportional 
to the daily dark period, whereby the period of melatonin release is termed ‘biological night’ 
(Arendt and Skene, 2005).  The synthesis of melatonin occurs through two enzymatic steps.  
Serotonin is firstly acetylated by serotonin N-acetyltransferase [arylalkylamine N-
acetyltransferase (AA-NAT)] to N-acetylserotonin.  Secondly, a methyl group from (S)-
adenosylmethionine is transferred to the 5-hydroxyindole-O-methyl-transferase (HIOMT) (Fig 
1.14) (Klein, 2007). 
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Figure 1.13.  Synthesis and regulation of melatonin.  The synthesis of melatonin by the pineal 
gland is controlled by the SCN, while G protein-coupled proteins, MT1 and MT2, respond to 
melatonin levels.  (Dubocovich et al., 2010) 
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Figure 1.14. Melatonin synthesis.  Melatonin is synthesized from serotonin through two 
enzymatic steps.  Firstly, serotonin is acetylated AA-NAT to N-acetylserotonin, after which a 
methyl group from (S)-adenosylmethionine is transferred to the HIOMT.  (Klein, 1999) 
 
Secretion of melatonin peaks during the daily dark phase (usually six to eight hours after the 
onset of darkness), but is very low during the day (light phase) (Dominguez-Rodriguez et al., 
2009; Reiter 1993).  Melatonin receptors, located in target tissues, respond to melatonin 
levels, according to the circadian rhythm, which allows for high melatonin levels at night.  
These G protein-coupled receptors, termed MT1 and MT2 are also potential therapeutic 
targets for a variety of disorders, ranging from insomnia and depression to cardiovascular 
diseases and cancer (Dubocovich et al., 2010).  Since melatonin has a limited duration of 
action, with a half-life of 0.54-0.67 hours in the blood, the synthesis of an analogue with a 
longer duration of action will be beneficial if used for its therapeutic value (Oxenkrug and 
Summergrad, 2010). 
Originally, melatonin was viewed only to have endocrine function, but even though it performs 
mainly hormonal functions, modern endocrinology has shown that certain hormones, including 
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melatonin exhibit additional actions and are therefore not strict classical hormones (Tan et al., 
2003).  In addition to the pineal gland, melatonin is secreted in a variety of organs (regarded 
as non-endocrine organs) and tissues, including the retina, Harder’s glands, gastroenteric 
mucous membrane, megakaryocytes, platelets, lymphocytes, bone marrow and skin, but at 
lower and varying rates (Claustrat et al., 2005, Slominski et al., 2012).  Earlier reports indicate 
that as much as 20% of circulating melatonin is not derived from the pineal gland (Gern and 
Norris, 1979).  
In humans melatonin is generally converted to 6-hydroxymelatonin by the liver, clearing up to 
97% of circulating melatonin in a single pass (Young et al., 1985).  The 6-hydroxymelatonin is 
conjugated and excreted into urine as a sulphate derivative and glucuronide to a lesser extent 
(Ma et al., 2008). 
 
1.6.2. Potential Health Benefits of Melatonin 
In addition to controlling circadian rhythms, melatonin has recently been shown to be a 
versatile biological signalling molecule (Pandi-Perumal et al., 2006), involved in many other 
physiological processes in humans and animals, including blood pressure control, regulation 
of the immune response and free radical scavenging, thus indicating its importance throughout 
the body (Hardeland et al., 2006, Rodella et al., 2013).  Under experimental conditions, chronic 
melatonin administration was demonstrated to be cardioprotective, which can be attributed to 
its free radical scavenging and antioxidant properties (Lochner et al., 2006, Nduhirabandi et 
al., 2011).  While other naturally-occurring antioxidants, such as vitamins E and C and 
glutathione are known to reduce oxidative damage at different sites and to varying degrees, 
melatonin seems to have an even greater efficacy, possibly due to its wide spread intracellular 
distribution throughout the body (Favero et al., 2014). 
Originally, melatonin was shown to detoxify the highly toxic hydroxyl radical (HO•) (Tan et al., 
1993).  It has since been shown that melatonin has the capability to scavenge hydrogen 
peroxide (H2O2) (Tan et al., 2000), hypochlorous acid (HOCl) (Zavodnik et al., 2004), 
superoxide anion radical (O2•-) (Ximenes et al., 2005) and peroxynitrite anion (ONOO-) (Reiter 
et al., 2001).  Melatonin and its metabolites are able to neutralize oxygen derivatives via a 
cascade reaction, which distinguishes melatonin from classic antioxidants.  This cascade 
enables one melatonin molecule to scavenge up to ten ROS versus classic antioxidants that 
are only capable of scavenging one or less ROS (Tan et al., 2003).  Melatonin also has the 
capacity to be induced under moderate oxidative stress, further distinguishing it from classic 
antioxidants (Tan et al., 2015).  The ability of melatonin to protect cells against oxidative stress 
more efficiently than other antioxidants has been demonstrated under in vivo conditions 
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(Tunez et al., 2007; Ortiz et al., 2013).  It has been demonstrated that excessive oxidative 
stress can lead to a rapid drop in circulating melatonin and is considered a protective 
mechanism for organisms against highly damaging oxidants.  Therefore, melatonin can be 
categorized as a first line defensive molecule (Tan et al., 1998).  The oxidative stress status 
of an organism modifies melatonin metabolism, whereby melatonin and its metabolites 
successively scavenge ROS via its free radical scavenging cascade (Tan et al., 2007).  
Aditionally, the toxicology effects of chronic melatonin exposure have been examined in both 
physiological and pharmacological amounts in humans and animals and it has been shown 
that the molecule is indeed nontoxic (Seabra et al., 2000). 
Melatonin has also been suggested to be atheroprotective and may slow the progression of 
atherosclerotic development (Favero et al., 2014).  Melatonin has been shown to act as a 
vasoconstrictor in the caudal artery and a vasorelaxant in the mesenteric artery and aorta 
(Slominski et al., 2012).  The combination of vasoconstriction and vasodilation responses can 
be attributed to melatonin receptors mediating the response, since both MT1 and MT2 are 
present in the cardiovascular system and MT1 receptors mediate vasoconstriction and MT2 
receptors mediate vascular dilatation (Masana et al., 2002).  It has been shown that melatonin 
enhances the clearance mechanism of endogenous cholesterol into bile, while also inhibiting 
cholesterol synthesis and LDL accumulation, thus exerting a hypocholesterolaemic action 
(Hussein et al., 2007).  Additionally, long term melatonin administration in a cholesterol fed rat 
model modified the fatty acid composition in plasma (Pita et al., 2002).  A six week melatonin 
treatment also reduced plasma LDL cholesterol levels in Zucker diabetic fatty rats, and also 
reduced blood glucose and plasma lipids in streptozotocin-induced diabetic rats (Montilla et 
al., 1998).  A known anti-inflammatory agent, melatonin could reduce molecular and cellular 
damage in blood vessels, even though the exact mechanisms have not yet been determined 
(Mauriz et al., 2013). 
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1.7. Problem Identification  
CVD is responsible for a rapidly growing number of deaths globally, and in South Africa where 
it is on the rise, specifically in the working age group (Steyn, 2007).  Worldwide diseases 
associated with tobacco addiction kill more than six million people a year and it is expected 
that this number could increase to more than eight million people a year by 2030 (World Health 
Organization, 2011).  Smoking, along with other cardiovascular risk factors, such as 
hypertension and diabetes, is associated with the development of ED, an early precursor of 
atherosclerosis (Cipollone et al., 2007). 
ED can result in atherosclerosis, which, in turn, is the underlying pathology for many 
cardiovascular diseases, often resulting in myocardial infarction or stroke (Lusis, 2000).  It has 
been shown that NO plays an important role in protection against the onset and progression 
of cardiovascular disease.  The ability of the endothelium to synthesise and release NO is 
essential in regulating haemostasis, vessel tone, blood pressure and vascular remodelling 
(Naseem, 2005).  Furthermore, the production of reactive oxygen species (ROS) and the 
resultant oxidative stress, are important mediators of the pathologic manifestations of 
endothelial dysfunction.  ROS reduce and eliminate the protective abilities of NO, which in turn 
will lead to endothelial dysfunction (Barua et al., 2003).  Experimental and clinical data indicate 
that exposure to nicotine increases oxidative stress and has the potential to induce endothelial 
dysfunction (Ambrose and Barua, 2004).   
It has been shown that early endothelial changes, such as ED, are reversible (Hsueh et al., 
2004). Therefore, it is clinically relevant to identify possible treatment modalities, such as 
antioxidant therapy, to counter the harmful effect of increased ROS production in order to 
restore the release of endothelioprotective NO.  Protecting the endothelium will result in 
reduced or delayed atherogenesis, lowering the risk of cardiovascular mortality.  Rooibos and 
melatonin are known to possess powerful antioxidant and cardioprotective effects and could 
help to reduce the harmful effects induced by nicotine.  In addition, no adverse effects of 
rooibos or melatonin administration have been identified (McKay and Blumberg, 2007 and Pita 
et al., 2002). 
Both rooibos and melatonin have been shown to display beneficial properties and could thus 
prove valuable in countering the harmful effect of nicotine as a risk factor for the development 
of cardiovascular disease.  The current study aims to address the lack of studies investigating 
the putative protective effects of rooibos and melatonin in the context of nicotine induced 
cardiovascular injury. 
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1.8. Research Aims and Objectives 
In order to answer the above research questions, the following research approach was 
followed: 
 
1.8.1. In vivo and ex vivo Pilot Study: Dose-response effect of nicotine exposure 
Prior to commencement of the principal study an in vivo pilot study was undertaken to 
determine the dose-response effect of nicotine exposure for 6 weeks in adult male Wistar rats 
on the following parameters: 
(i) Vascular function by means of contraction and relaxation studies in aortic rings 
harvested from treated and untreated male Wistar rats 
(ii) Oxidative stress parameters by means of the thiobarbituric acid reactive substances 
(TBARS) assay in serum samples 
(iii) Blood pressure measurements by means of the non-invasive tail-cuff method 
 
1.8.2. Main in vivo and ex vivo study 
Aim 1:  To establish an in vivo model in which the effects of nicotine were assessed. 
The optimal injury inducing-concentration of nicotine, as established in 1.8.1. was used in the 
main study. Nicotine-induced injury was assessed by investigating the following endpoints: 
(a) Blood pressure measurements by means of the non-invasive tail-cuff method 
(b) Vascular function in aortic tissue harvested from treated and untreated male Wistar 
rats.  This is supported by an in vitro model of adult rat aortic endothelial cells (AECs), in which 
endothelial nitric oxide production and cell viability were assessed. 
(c) Antioxidant enzyme activity and oxidative stress status.  Superoxide dismutase (heart 
and liver tissue), catalase (heart and liver tissue) and glutathione peroxidase (heart tissue) 
assays were conducted to determine antioxidant enzyme activity and concentrations of 
conjugated dienes and TBARS (serum samples) analysed as measures of the oxidative stress 
status. 
(d) Inflammatory markers, including TNF-α, IL-6 and CRP was analysed in serum samples 
(e) Serum  was analysed for total cholesterol, triglycerides and phospholipid 
concentrations in order to establish a serum lipid profile 
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Aim 2:  To determine whether co-treatment of nicotine with rooibos (unfermented and 
fermented) affects the nicotine-induced endpoints as described in Aim 1. 
Aim 3:  To determine whether co-treatment of nicotine with melatonin affects the nicotine-
induced endpoints as described in Aim 1. 
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CHAPTER 2: MATERIALS AND METHODS 
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The study used healthy adult male Wistar strain rats throughout the pilot study and main study 
(Fig 2.1).  The in vivo studies comprised a six week treatment period of subcutaneously 
administered nicotine or subcutaneously administered nicotine and rooibos (fermented or 
unfermented) or melatonin co-treatments.  Rooibos and melatonin were given in the drinking 
water and appropriate subcutaneous and oral (fluid) controls were included.  The ex vivo 
studies utilised aortas obtained from male Wistar rats after the abovementioned six week 
treatment period.  The aortas were used in organ bath based vascular contraction-relaxation 
investigations.  Ex vivo studies were supported by in vitro investigations in a model of adult rat 
aortic endothelial cells.  The results of the investigations will follow in Chapter 3. 
 
 
Figure 2.1.  Healthy adult Wistar rat (www.scientificchicago.com). 
 
2.1. General Materials Used 
• (-) - Nicotine – Sigma-Aldrich (St. Louis, MO, USA) (CAS number: 54-11-5) 
• Rooibos (Fermented and Unfermented) – Gift from the PROMEC unit of the South 
African Medical Research Council  
• Melatonin – Sigma-Aldrich (St. Louis, MO, USA) (CAS number: 73-31-4) 
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2.2. Animal Care 
Ethics approval was received from Stellenbosch University; Project number SU-ACUM12-
00041 and experiments were conducted according to ‘The Revised South African National 
Standard for the Care and Use of Animals for Scientific Purposes (South African Bureau of 
Standards, SANS 10386, 2008)’.  Healthy, pathogen free adult male Wistar rats, weighing 
between 220-310 g at the start of the study, were housed at room temperature (23°C ± 2°C) 
in the Central Animal Housing Unit of the Faculty of Medicine and Health Sciences, 
Stellenbosch University.  Animals were housed under normal 12 hour light and 12 hour dark 
cycles and had free access to standard rat chow and fluids.  Animals were randomly assigned 
to treatment groups and individually caged in order to monitor fluid intake and were weighed 
on a regular basis.  Animals receiving injectable treatments (nicotine and saline) were weighed 
daily and animals receiving only fluid as treatment (rooibos and melatonin) were weighed twice 
a week.  Animals were euthanized with an overdose of sodium pentobarbital (160 mg/kg) by 
means of intra-peritoneal injection, before collecting blood, harvesting organs and excising 
aortas.  Even though only heart and liver tissue were used in the study, the lungs, kidneys, 
pancreas and testes were also collected and frozen for possible use in future studies, thereby 
adhering to the principles of reduction and refinement of ethical animal use.  The weight of 
each organ (heart, liver, lungs, kidneys, pancreas and testes) was also recorded. 
 
2.3. Drug Administration 
2.3.1. Physiological Saline 
0.9 % Physiological saline was made up by dissolving 0.9 g NaCl in 100 ml double distilled 
water and thereafter autoclaved.  The autoclaved saline solution was divided into 10 ml 
aliquots in sterile tubes and stored at 4°C.  Aliquots were left on the bench to equilibrate to 
room temperature before it was administered to the rats via subcutaneous injection.  Rats 
were weighed daily to determine the injection volume required.  A new, sterile 26G needle was 
used for each injection. 
 
2.3.2. Nicotine (1 mg/kg bw/day; 2 mg/kg bw/day; 5 mg/kg bw/day) 
Nicotine was dissolved in sterile 0.9 % physiological saline (prepared as described under 
section 3.1.) according to the concentration required.  Tubes of nicotine were wrapped in foil 
and stored at 4°C. Aliquots were left on the bench to equilibrate to room temperature before it 
was administered to the rats via subcutaneous injection.  Rats were weighed daily to 
Stellenbosch University  https://scholar.sun.ac.za
 37 
 
determine the injection volume required.  A new, sterile 26G needle was used for each 
injection.  Fresh nicotine was made up on a weekly basis. 
 
2.3.3. 2% Rooibos (Fermented and Unfermented) 
Fermented and unfermented rooibos were both made up from dried leaves according to the 
same procedure.  Twenty g dried leaves were added to 1 l of boiling tap water and allowed to 
steep for 30 minutes, while stirring occasionally.  The steeped solution was filtered through 
cheese cloth and then through number 4 filter paper (65 g/m2).  Lastly, the solution was filtered 
through a number 1 filter paper (84 g/m2).  Filtered rooibos was transferred to dark plastic 
bottles and stored at 4°C.  Fresh rooibos was made up on a weekly basis.  These 
concentrations are customarily used for tea making purposes and the protocol used conforms 
to the established method of rooibos preparation for experimental purposes (Marnewick et al., 
2003).  The rooibos solution served as the drinking fluid in the cages housing the rats assigned 
to the rooibos experimental groups.   
 
2.3.4. Melatonin 4 mg/kg bw/day 
Melatonin was weighed, dissolved in 1 ml absolute ethanol and then added to the drinking 
water at a final concentration of 0.05% (v/v) ethanol with melatonin.  The final melatonin 
solution was then transferred to dark bottles.  Fresh melatonin was made up on a daily basis.  
Rat fluid intake was recorded daily to ensure that the correct concentration of melatonin was 
received.  The melatonin solution served as the drinking fluid in the cages housing the rats 
assigned to the melatonin experimental groups. 
 
2.4. Soluble Solids, Total Polyphenols and Flavonoid Content Determinations of 
Rooibos 
All determinations were performed for both 2% fermented rooibos and 2% unfermented 
rooibos, the concentration administered to rats throughout the study. 
 
2.4.1. Soluble Solids 
Soluble solid content of rooibos was determined gravimetrically.  Clean, dry glass bottles were 
weighed prior to adding 1 ml aliquots of rooibos.  The aliquots were dried at 70°C for 24 hours 
and subsequently placed in a desiccator for 24 hours.  Glass bottles were again weighed after 
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the drying period and initial weight of empty bottle subtracted to determine the soluble solid 
content.  Determination of soluble solids were repeated six times on the same preparation. 
 
2.4.2. Total Polyphenols 
Total polyphenol content was determined by ARC Infruitec-Nietvoorbij, Post-Harvest Wine 
Technology Division, Stellenbosch, South Africa, using the Folin-Ciocalteu’s phenol reagent.  
Briefly, 100 µl Folin-Ciocalteau reagent and 80 µl 7.5% (m/v) Na2CO3 were added to 20 µl 
blank (deiH2O), standards (gallic acid; 10-100 mg/l in deiH2O) or appropriately diluted rooibos 
in a 96 well plate and allowed to stand at room temperature for two hours (Arthur et al., 2011).  
Absorbance was read at 765 nm and expressed as mg gallic equivalents per mg soluble 
solids. 
 
2.4.3. Flavonoid Content 
2.4.3.1. Flavonol and Flavanol Determination 
Flavonol content was spectrophotometrically determined at 360 nm, using a Spectronic® 20 
GenesysTM photospectrometer (Spectronic Instruments, Leeds, UK) and utilised quercetin as 
standard.  Both quercetin and rooibos were diluted in 95% ethanol.  Flavanol content was 
spectrophotometrically determined at 640 nm, using a Spectronic® 20 GenesysTM 
photospectrometer (Spectronic Instruments, Leeds, UK) using the 4-(dimethylamino)-
cinnamaldehyde (DAC) reaction.  DAC and rooibos were dissolved in HCl-MeOH (1:3).  
Catechin was dissolved in methanol to make a 0.05% solution and this served as standard for 
the flavanol determinations.  For both flavonol and flavanol determinations the optimal dilution 
factor of rooibos was determined and subsequent analysis performed in triplicate (Ajuwon et 
al., 2013). 
 
2.4.3.2. Analysis for Known Flavonoid Compounds 
Known flavonoid compounds were determined by HPLC analysis by ARC Infruitec-Nietvoorbij, 
Post-Harvest Wine Technology Division, Stellenbosch, South Africa according to the HPLC 
method described in Joubert et al., 2012.  Analyses were performed on an Agilent 1200 
system (Agilent, Santa Clara, California, USA).  Stock solutions of phenolic standards were 
prepared in dimethylsulfoxide (DMSO) at concentrations of 1 mg/ml and diluted with water 
according to experimental requirements and filtered through 0.22 µm polyvinylidene difluoride 
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filters prior to use.  Nine-point calibration curves were set up for all standards to test the 
linearity of the ultraviolet (UV)-diode array detector (DAD) response.  The dihydrochalcones 
and phenylpyruvic acid-2-O-glucoside (PPAG) were quantified at 288 nm, while the flavones, 
flavonols, and ferulic acid were quantified at 350 nm. The calibration mixtures were injected 
at varying injection volumes, leading to levels of 0.025−1.20 μg on-column. Concentration 
ranges were selected to cover the different quantities of the compounds present in aqueous 
rooibos infusions. Linear regression, using the least-squares method (Microsoft Excel 2003, 
Microsoft Corporation, Redmond, WA), was performed on the calibration curve data for each 
compound to determine the slope, y intercept, and correlation coefficients (r2).    Results are 
expressed as mg per litre. 
 
2.5. In vivo and Ex vivo Investigations: Pilot Study: Dose-response Effect of Nicotine 
Exposure: 1 mg/kg bw/day Nicotine vs 2 mg/kg bw/day Nicotine 
Prior to commencement of the main study, a pilot study was undertaken to assess the injury 
inducing properties of two previously described nicotine concentrations over a six week 
treatment period.  Nicotine was subcutaneously administered at concentrations of 1 mg/kg 
bw/day or 2 mg/kg bw/day (Benowitz and Jacob, 1999, Balakumar et al., 2008b).  
Physiological saline, subcutaneously administered, served as vehicle control.   
 
2.5.1. Treatment Groups 
A total of 15 rats were divided into three groups (nicotine 1 mg/kg bw/day: n = 5; nicotine 2 
mg/ml bw/day: n = 5; physiological saline: n = 5) (Fig 2.2).   
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Figure 2.2. Treatment groups for the dose-response effect of nicotine – Pilot study.  Nicotine 
and physiological saline (vehicle control) were administered subcutaneously. 
 
2.5.2. Specific Endpoints Measured 
• Blood pressure measurements by means of the non-invasive tail-cuff method 
• Vascular function by means of aortic ring isometric tension studies 
• Oxidative stress parameters by means of the TBARS assay kit (Cayman Chemical 
Company, Ann Arbor, MI, USA) 
 
 
  
Male Wistar 
Rats (n = 15)
Nicotine 1 mg/kg 
bw/day (n=5)
Nicotine 2 mg/kg 
bw/day (n=5)
Vehicle Control 
(n=5)
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2.6. In vivo and Ex vivo Investigations: Main Study 
2.6.1. Treatment Groups 
A total of 90 rats were divided into nine groups.  Since neither 1 mg/kg bw/day nor 2 mg/kg 
bw/day nicotine concentrations resulted in sufficient injury, it was decided to opt for a higher 
concentration of nicotine, namely 5 mg/kg bw/day (Zimmerman and McGeachie, 1985).  
Nicotine and a saline vehicle control were administered subcutaneously.  Rats were weighed 
on a daily basis to determine injection volume.  Co-treatments consisted of 5 mg/kg bw/day 
administered with either 2% rooibos (fermented or unfermented) or 4 mg/kg bw/day melatonin.  
Control groups included a drinking control (tap water), as well as rooibos (fermented and 
unfermented) and melatonin groups.  Rooibos (fermented and unfermented) and melatonin 
were supplied as drinking fluids.  Each group contained 10 rats, resulting in a total of nine 
treatment groups (Fig 2.3).  A schematic overview of the main in vivo study is given in figure 
2.4. 
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Figure 2.3. Treatment groups for the main in vivo study. 
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2.6.2. Specific Endpoints 
• Blood pressure measurements by means of the non-invasive tail-cuff method 
• Vascular function by means of aortic ring isometric tension studies, complemented by 
in vitro studies in cultured adult rat aortic endothelial cells  
• Antioxidant enzyme activity and oxidative stress status determinations 
• Inflammatory marker determinations 
• Serum lipid measurements 
 
Figure 2.4. Schematic overview of the in vivo investigations carried out in the main study. 
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2.7. General Experimental Procedures 
2.7.1. Blood Pressure Measurements 
Blood pressure of rats was measured non-invasively on a weekly basis by means of the 
volume-pressure recording (VPR) tail-cuff method, which calculates blood pressure by 
determining tail blood volume with a sensor and occlusion tail cuff (CODATM System, Kent 
Scientific) (Fig 2.5).  The rats were acclimatized to the apparatus for one week prior to 
measurements. 
 
       
Figure 2.5. Blood pressure measurement in a male Wistar rat using the CODATM system (Kent 
Scientific).   Rat in rodent holder on heating platform.  VPR and occlusion cuffs are attached 
to the tail. 
 
2.7.2. Sample Collection 
Rats were fasted overnight and euthanized with an overdose of sodium pentobarbital (160 
mg/kg).  Blood was collected and allowed to clot on ice for 30 minutes.  After 30 minutes the 
blood was centrifuged at 1200 g for 10 minutes at 4°C and serum collected.  The serum was 
aliquoted and stored at -80°C for further analysis.  Organs, including the heart, lungs, liver, 
pancreas and testes were harvested, rinsed, weighed and flash frozen in liquid nitrogen.  
Tissue samples were stored at -80°C for further analysis.  The aorta was excised, cleaned of 
excess tissue and perivascular fat, and used immediately for vascular contraction / relaxation 
experiments.  The sample collection procedure is described in figure 2.6. 
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Figure 2.6. Sample collection procedure. 
 
2.7.3. Ex vivo Investigations: Aortic Ring Isometric Tension Studies 
2.7.3.1. Excision and Mounting of Rings 
The thoracic aorta was excised and immediately placed in ice cold Krebs Henseleit buffer 
(KHB, composition in mM: NaCl 119, NaHCO3 25, KCl 4.75, KH2PO4 1.2, MgSO4.7H2O 0.6, 
Na2SO4 0.6, CaCl2.H2O 1.25 and glucose 10).  All connective tissue and perivascular fat were 
removed and the aorta was cut into 3-4 mm segments.  The cleaned aortic ring was mounted 
onto two stainless steel hooks and lowered into a 25 ml organ bath (AD Instruments, Bella 
Vista, New South Wales, Australia) (Fig 2.7 and Fig 2.8).  The organ bath contained 
oxygenated (95% O2 and 5% CO2) KHB.  The tension of the aortic ring was recorded (grams 
of tension) with an isometric force transducer (TRI202PAD, Panlab, ICornellà, BCN, Spain) 
and the data analysed with LabChart 7 software (Dunedin, New Zealand). 
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Figure 2.7. Organ bath and transducer used for aortic ring studies. 
 
 
Figure 2.8. Aortic ring suspended between two stainless steel hooks and lowered into organ 
bath (from Loubser D, MSc thesis, Stellenbosch University, April 2014). 
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2.7.3.2. Experimental Protocol 
The experimental protocol was based on a modified protocol of isometric tension 
measurement (Privett et al., 2004).  The protocol can be divided into an initial stabilisation 
phase, followed by a first round of contraction and relaxation in order to establish the 
functionality of the endothelium.  The first round of contraction and relaxation was followed by 
a second stabilisation phase.  This was followed by a round of cumulative contraction and 
cumulative relaxation. 
 
2.7.3.2.1. First Round Stabilisation 
The mounted aortic ring was lowered into the organ bath and thereafter it was subjected to a 
30 minutes stabilisation period.  The resting tension of the aortic ring was increased to 1.5 g 
during this period.  The KHB was changed every 10 minutes with pre-warmed KHB (37°C). 
 
2.7.3.2.2. First Round Contraction / Relaxation 
A first round of contraction with phenylephrine (Sigma-Aldrich, St. Louis, MO, USA) (100 nM) 
and relaxation with acetylcholine (Sigma-Aldrich, St. Louis, MO, USA) (10 µM), added directly 
into the organ bath, was carried out in order to test the functionality of the endothelium.  
Phenylephrine (Phe) is an α-adrenergic receptor agonist which leads to smooth muscle 
contraction though its direct action on the vascular smooth muscle cells, whereas 
acetylcholine (ACh) binds to endothelial surface receptors, which results in increased 
intracellular calcium levels and consequently eNOS activation.  The subsequently released 
NO diffuses into the underlying smooth muscle cells leading to relaxation.  ACh was added to 
the organ bath after the Phe-induced contraction reached a plateau.  Rings that showed at 
least a 70% relaxation of maximum Phe-induced contraction were deemed viable and used 
for further investigations. 
 
2.7.3.2.3. Second Round Stabilisation 
Following the first round of contraction/relaxation the organ bath was rinsed three times with 
KHB in order to flush out Phe and ACh.  The rings were again stabilised for 30 minutes at 1.5 
g, as described in 2.7.3.2.1. 
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2.7.3.2.4. Second Round Cumulative Contraction / Relaxation 
Phe was used to induce cumulative aortic ring contractions.  The step-wise increase in total 
Phe concentration was as follows: 100 nM, 300 nM, 500 nM, 800 nM, 1 µM.  After the 
maximum Phe-induced contraction was reached, ACh was cumulatively added to induce 
relaxation.  The step-wise increase in total ACh concentration was as follows: 30 nM, 100 nM, 
300 nM, 1 µM, 10 µM.  The final concentration of ACh resulted in maximum % relaxation of 
contraction and was the endpoint of the experiment.  Figure 2.9 shows a timeline of the 
experimental protocol. 
 
 
Figure 2.9. Timeline of the aortic ring studies experimental protocol.  (From Vascular 
Reactivity: Aortic ring protocol, Laboratory Manual, Stellenbosch University, Westcott C, 
2015.) 
 
2.7.3.3. Statistical Analysis 
Data were analysed using GraphPad Prism® 5 software (GraphPad Software, San Diego, CA, 
USA).  All aortic ring isometric tension data are expressed as the % contraction from a resting 
tension of 1.5 g or % relaxation of maximum contraction respectively.  Data were statistically 
analysed by means of two-way analysis of variance, followed by the Bonferroni post-test.  
Differences with a p-value < 0.05 were considered statistically significant. 
Stellenbosch University  https://scholar.sun.ac.za
 49 
 
2.7.4. In vitro Investigations 
2.7.4.1. General Materials Used 
• Endothelial cell growth medium (EGM-2) – Clonetics (Cambrex Bio Science, 
Walkersville, USA) 
• Attachment factor (solution containing gelatine) – Life Technologies (Carlsbad, 
California, USA) 
• Trypsin (solution containing 2.5% trypsin) - Life Technologies (Carlsbad, California, 
USA) 
• Foetal bovine serum (FBS) – Highveld Biological (Lyndhurst, RSA) 
• Nicotine – Sigma-Aldrich (St. Louis, MO, USA) (CAS number: 54-11-5) 
• Rooibos (Fermented) – Gift from the PROMEC unit of the South African Medical 
Research Council 
 
2.7.4.2. Aortic Endothelial Cells (AECs) 
Adult rat AECs cultures were purchased commercially from VEC Technologies (Rensselaer, 
New York, USA).  Cells were grown to confluency in a standard tissue culture incubator 
(Forma Series II, Thermo Electron Corporation, Waltham, MA, USA) at an atmospheric 
composition of 21% O2, 5% CO2, 40-60% humidity and temperature was maintained at 37°C.   
 
2.7.4.3. Passaging Procedures 
Cells were received in 75 cm2 tissue culture flasks, supplied with fresh growth media (EGM-
2) and allowed to grow until confluent in a standard tissue culture incubator under the 
conditions described above.  Cells received fresh EGM-2 every second day thereafter.  The 
growth medium was supplemented with 10% FBS and standard endothelial growth factors 
(vascular endothelial growth factor (VEGF), human epidermal growth factor (hEGF), long 
chain human insulin-like growth factor (R3-IGF-1), human fibroblastic growth factor (hFGF), 
hydrocortisone, antibiotics (gentamicin and amphotericin B) and ascorbic acid), according to 
the manufacturer’s instructions.  Confluency was evaluated by microscopic observation, 
demonstrating that the cells were evenly distributed and completely covered the growth area 
of the tissue culture flask.  When confluency was reached cells were washed with phosphate 
buffered saline (PBS) and incubated with pre-warmed (37°C) solution containing 2.5% trypsin 
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to allow cells to detach.  The isolated cell-trypsin mixture was immediately transferred into 15 
ml conical tubes containing fresh EGM-2 and centrifuged for three minutes at 1000 rpm.  The 
supernatant was removed and the pellet resuspended in fresh EGM-2.  Passaging to the next 
generation was performed in a 1:2 ratio.  Cell aliquots were stored in a special “freezing” 
medium of 90% FBS, 5% cell growth medium and 5% DMSO, and stored in liquid nitrogen for 
subsequent use.  
Cell aliquots taken from liquid nitrogen for experimental purposes were allowed to thaw in the 
tissue culture incubator (10-15 min) and seeded in two, attachment factor coated, 35 mm petri 
dishes.  Fresh growth medium was given the next day and cells were allowed to grow until 
confluent.  Cells were then passaged in the manner described above, by which passaging to 
the next generation was performed in a 1:2 ratio.  According to this method, a P1 cell line 
could result in 128 petri dishes, a P2 cell line in 64 petri dishes and a P3 cell line in 32 petri 
dishes.   
 
2.7.4.4. General In vitro Methods 
2.7.4.4.1. Flow Cytometric Analysis 
Flow cytometric analysis of all fluorescent probes utilised in the in vitro study were performed 
on a Becton-Dickinson FACSCalibur flow cytometer (Franklin Lakes, NJ, USA) and data was 
analysed by means of the WinMDI® 2.9 software package (Purdue University Cytometry 
Laboratories, West Lafayette, USA).  A total of 10 000 cells were analysed for each 
experimental sample, while control and appropriate positive controls were added for each 
probe.  Cell populations (healthy cells, excluding debris and non-cellular particles) of control 
samples were gated and gate coordinates used for experimental samples in the same flow 
cytometry session.  The probes used in this study are listed in Table 2.1.   
 
Table 2.1.  Fluorescent probes used in the in vitro study.   
Endpoint Flow cytometric analyses 
NO production 4,5-diaminofluorescin-2 diacetate (DAF-
2/DA) fluorescence 
Apoptosis Annexin-V fluorescence 
Necrosis Propidium iodide (PI) fluorescence 
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2.7.4.4.2. Measurement of Nitric Oxide Production 
NO production was measured by 4,5-diaminofluorescin-2  diacetate (DAF-2/DA) fluorescence 
(Calbiochem, San Diego, CA, USA), which is a non-fluorescent cell permeable reagent 
capable of measuring free NO and NOS activity in living cells.  After entering the cell, the 
diacetate groups on the DAF-2/DA are hydrolysed by cytosolic esterases, which release the 
DAF-2.  NO converts the non-fluorescent dye to its fluorescent triazole derivative, DAF-2T.  
DAF-2T fluorescence can be analysed in flow channel 1 of the flow cytometer.  The protocol 
for measurement of NO production by DAF-2/DA has previously been established in our 
laboratory (Strijdom et al., 2004 and 2006). 
 
A       B  
Figure 2.10. A shows a scatterplot with gating of the population of interest.  Only the events 
within the gate will be represented on the histogram.  B shows a histogram of FL1-H (x-axis), 
in this case a mean fluorescence intensity (Mn) of 8.82 was obtained. 
 
2.7.4.4.3. Experimental Protocol and Data Analysis 
When cells had reached confluency, petri dishes were randomly assigned to control, positive 
control and treatments groups.  One petri dish was reserved to serve as absolute control and 
remained free of any treatments and the probe.  After the treatment period, cells were washed 
twice with PBS and incubated with 10 µM DAF-2/DA probe for two hours.  The positive control, 
100 µM diethylamine NONOate diethylammonium salt (DEA/NO) (Sigma-Aldrich, St Louis, 
MO, USA), which is an NO donor, was added to positive control petri dishes for the last 30 
min of the two hour DAF-2/DA incubation period (Fig 2.12).  After the incubation period, the 
probe was aspirated, cells washed with PBS and trypsinized into a 15 ml conical tube 
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containing cell staining buffer.  Cell staining buffer (Bio-Legend, Biochom-Biotech, San Diego, 
CA, USA) was used at this stage of experimentation, since it is colourless.  Cell growth media 
has a pink colour, which could interfere with the flow cytometric analysis, which is based on 
fluorescent colour emission.  Cell suspensions were centrifuged for three minutes at 1000 
rpm, after which the supernatant was aspirated.  Cell pellets were resuspended in PBS and 
transferred to FACS tubes for flow cytometric analysis.  A schematic representation of the 
protocol is given in figure 2.11. 
 
 
Figure 2.11.  Schematic representation of the protocol used for DAF-2/DA probe and the 
positive control DEA/NO. 
 
 
Figure 2.12.  DEA/NO (100 µM, 30 min) significantly increased mean DAF-2/DA fluorescence 
when compared to controls.  DEA/NO served as positive NO control in the study. 
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2.7.4.4.4. Measurement of Apoptosis and Necrosis (Cell Viability) 
Cell viability was assessed by Anexa Fluor® 647 Annexin V conjugate, which is a marker of 
apoptosis, and propidium iodide (PI) which is a marker of necrosis (Bio-Legend, Biochom-
Biotech, San Diego, CA, USA).  For experiments in which only necrosis was measured, PI 
was obtained from Sigma-Aldrich (St. Louis, MO, USA).  Annexin V binds to 
phosphatidylserine on the outer membrane, enabling it to identify cells undergoing apoptosis.  
Annexin V fluorescence is measured in flow channel 4 of the flow cytometer.  PI is an 
intercalating agent, which can enter the nucleus of a cell when membrane integrity is lost due 
to cell death (Wilkins et al., 2002).  PI fluorescence is measured in flow channel 2 of the flow 
cytometer. 
 
2.7.4.4.5. Experimental Protocol and Data Analysis 
When cells had reached confluency, petri dishes were randomly assigned to control, positive 
control and treatments groups.  A positive control for cell death, namely distilled H2O was 
added for five min.  After the treatment period, cells were washed twice with PBS and 
trypsinized into 15 ml conical tubes containing cell staining buffer and centrifuged for 2 min at 
700 rpm.  After centrifugation, the cell staining buffer was aspirated and the cell pellet 
resuspended in binding buffer (Bio-Legend, Biochom-Biotech, San Diego, CA, USA) and the 
cell suspension transferred to a FACS tube.  Annexin V (final concentration: 5 µM) and PI 
(final concentration: 5 µM) were added to the tube and incubated for 15 min in the dark.  Flow 
cytometric analysis was carried out after the incubation period.  When using Annexin V and 
PI in the same experiment, parameters could be simultaneously measured and analysis 
carried out by creating quadrants of the gated populations.  The use of quadrants allowed for 
discrimination between apoptotic and necrotic populations (Fig 2.13 and Fig 2.14).  Distilled 
H2O served as positive control for necrosis, whereby cells were washed with PBS and then 
treated with dH2O for five minutes.  H2O is an appropriate control for necrosis, since it will 
diffuse across a semi-permeable membrane from an area with low osmolarity (outside the cell) 
to an area of high osmolarity (inside the cell).  As H2O moves into the cell, the cell will swell 
and the cell membrane rupture, allowing PI to enter and bind DNA (Fig 2.15).  
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Figure 2.13.  A density plot showing the quadrants used for simultaneous analysis of necrosis 
and apoptosis.  PI was measured in the FL2-H channel (y-axis) and Annexin V in the FL4-H 
channel (x-axis). 
 
 
Figure 2.14.  Density plot showing quadrants used for data analysis of propidium iodide-
stained necrotic cells only.  The lower left quadrant shows the percentage viable cells and the 
lower right quadrant shows the percentage necrotic cells. 
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Figure 2.15.  dH2O served as positive control for PI experiments, resulting in a significant 
increase in PI fluorescence when compared to controls. 
 
2.7.4.5. Nicotine and Rooibos Experimental Protocols 
2.7.4.5.1. Nicotine Dose-response Experiments 
An optimal injury inducing concentration of nicotine had to be established for AECs.  Nicotine 
was diluted with PBS and the following concentrations were tested for resultant decline in NO 
production and increase in necrosis and apoptosis, when compared to controls: 1 µM; 10 µM 
and 100 µM.  Nicotine at a concentration of 1 µM is typically found in the bloodstream of those 
who smoke one pack of cigarettes a day (Dasgupta et al., 2006; Alamanda et al., 2012).  A 
treatment period of 24 hours was used for all experiments.  NO production and necrosis and 
apoptosis were determined according to the protocols described in section 2.7.4.4.2 and 
2.7.4.4.4. 
 
2.7.4.5.2. Rooibos Dose-response Experiments 
An optimal concentration of fermented rooibos (RF) for use on AECs had to be established.  
A treatment period of 24 hours was used for all experiments.  NO production and necrosis 
were determined according to the protocols described in section 2.7.4.4.2 and 2.7.4.4.4.  RF 
concentrations ranging between 0.015 mg/ml and 0.5 mg/ml were tested. 
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2.7.4.5.3. Preparation of Fermented Rooibos (RF) 
RF was prepared according to the protocol described in section 2.3.3.  RF was freeze dried in 
a FreeZone6 (Labconco, Kansas City, MO, USA) freeze drier to remove the aqueous fraction.  
100 ml RF was used per 250 ml vacuum flask and shelled in liquid nitrogen.  RF was freeze 
dried overnight (± 24 hours), transferred to 15 ml conical tubes and stored in a desiccator.  
Freeze dried RF was made up to a 20 mg/ml stock solution in cell culture media and further 
diluted in cell culture media according to the concentration required. 
 
2.7.4.6. Nicotine with Fermented Rooibos (RF) Pre-treatment: Administration and 
Experimental Layout 
Cells were co-treated with nicotine and RF after determining the optimal concentrations of 
nicotine and RF for AECs, to determine if RF could reduce the damage caused by nicotine.  
NO production and necrosis were measured as described in section 2.7.4.4.2 and 2.7.4.4.4.  
Cells were pre-treated with RF for one hour, after which nicotine was added for a further 24 
hours.   
 
2.7.4.7. Statistical Analysis 
All flow cytometric data were calculated as mean ± standard error of the mean.  Controls were 
adjusted to 100 % and values expressed as a % of the control.  The Student’s t-test or one-
way analysis of variance (with Bonferroni multiple comparison test) were used to determine 
statistical significance.  Data were analysed using GraphPad Prism® 5 software (GraphPad 
Software, San Diego, CA, USA) and differences with a p-value of <0.05 regarded as 
statistically significant.  Experiments were repeated at least once to result in a sample size of 
6-8 per group.  Sample sizes are indicated below each graph in Chapter 3. 
 
2.7.5. Tissue Homogenate Preparation 
Heart and liver homogenates were prepared from the snap-frozen tissue samples obtained 
after euthanasia and subsequently stored at -80°C (described in Section 7.2).  Tissue 
homogenates were prepared in microcentrifuge tubes using the Bullet Blender 24 (Next 
Advance, NY, USA).    The recommended Next Advance protocols for heart and liver 
homogenization for small samples were used as guidelines.  Briefly, a small amount of tissue 
(± 100 mg) and equal amount of homogenization beads were weighed and two volumes of 
buffer (50 mM sodium phosphate, pH 7.5) added.  For liver tissue 0.5 mm zirconium oxide 
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beads were used and for heart tissue 1.6 mm stainless steel beads were used.  Samples were 
kept cold at all times and homogenization took place at 4°C.  Samples were homogenized for 
one minute and then rested for one minute to ensure samples remained cold.  After 
satisfactory homogenization was achieved, samples rested on ice for 30 minutes.  Samples 
were then centrifuged at 12000 rpm for 20 minutes, after which the supernatant was 
transferred to a clean microcentrifuge tube.  Homogenates were diluted with buffer and 
aliquots stored at -80°C.  An additional centrifugation step was employed for heart 
homogenates to allow for separation of cytosolic and mitochondrial fractions.  The original 
supernatant was transferred to a clean microcentrifuge tube and centrifuged at 14000 rpm for 
20 minutes.  The supernatant (cytosolic fraction) was transferred to a clean microcentrifuge 
tube, diluted with buffer and aliquots stored at -80°C.  The pellet (mitochondrial fraction) was 
resuspended in buffer and washed by means of centrifugation.  The resulting pellet was diluted 
with buffer and aliquots stored at -80°C.  An overview of the homogenization process is given 
in figure 2.16. 
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Figure 2.16.  Heart and liver tissue homogenization using the Bullet Blender 24 by Next 
Advance (NY, USA). 
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2.7.6. Protein Quantification of Homogenates 
For the determination of the protein quantity of each tissue homogenate, the bicinchoninic acid 
(BCA) protein assay kit (BCA1 and B9643) by Sigma-Aldrich (St Louis, MO, USA) was utilised.  
The assay relies on the formation of a Cu2+-protein complex under alkaline conditions, followed 
by reduction of the Cu2+ to Cu1+, whereby the amount of reduction is proportional to the amount 
of protein present.  BCA forms a stable purple complex with Cu1+ in alkaline environments, 
which forms the basis of the colourimetric assay.  The micro-method, as described in the kit 
insert, makes use of a 96 well plate, was used for all assays.  The protocol provided with the 
BCA assay kit was used.  Reagent A (BCA solution) and Reagent B (copper (II) sulfate 
pentahydrate 4% solution) were mixed in a 50:1 ratio to form the green BCA Working Reagent.  
Bovine serum albumin (BSA) (Sigma-Aldrich, St Louis, MO, USA) served as standard.  A stock 
of 1 mg/ml was diluted with deionized water (deiH2O) to concentrations ranging from 0.2 mg/ml 
to 0.8 mg/ml to derive a standard curve (Fig 2.17).  Tissue homogenates were diluted with 
deiH2O to bring them within the linear concentration range of 200-1000 µg/ml of protein.  To 
each well, 25 µl of protein (standard or sample) and 200 µl BCA Working Reagent was added.  
A blank was also included.  Plates were incubated at 37°C for 30 minutes and absorbance 
read at 562 nm in a FLUOstar Omega Microplate Reader (BMG Labtech, Offenburg, 
Germany).  The assay was performed in triplicate for all samples.   
 
 
Figure 2.17. Example of BCA assay standard curve.  BSA served as standard and 
absorbance was read at 562 nm. 
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2.7.7. Antioxidant Enzyme Activity and Oxidative Stress Status 
2.7.7.1. Superoxide Dismutase 
Superoxide dismutases (SODs) form a crucial part of the cellular antioxidant defence 
mechanism.  These metalloenzymes catalyse the dismutation of the superoxide anion to 
molecular oxygen and hydrogen peroxide through the following reaction: 2O2•- + 2H+ + SOD 
→ H2O2 + O2.  The Superoxide Dismutase Assay Kit (706002) by the Cayman Chemical 
Company (Ann Arbor, MI, USA) was utilised for the detection of superoxide radicals generated 
by xanthine oxidase and hypoxanthine (Fig 2.18).  The assay measured all three types of SOD 
(Cu/Zn, Mn, and FeSOD) and one unit of SOD was defined as the amount of enzyme needed 
to exhibit 50% dismutation of the superoxide free radical.  Tetrazolium salt was used for the 
detection of superoxide radicals and bovine erythrocyte SOD (Cu/Zn) served as standard.  
Liver and heart (mitochondrial fraction) homogenates, prepared as described in section 2.7.5 
and stored at -80°C, were thawed on ice and diluted in sample buffer (50 mM Tris-HCl, pH 
8.0) as necessary.  Radical detector was added to standards and samples in a 96 well plate 
and the reaction initiated by adding xanthine oxidase.  The 96 well plate was incubated on a 
shaker for 30 minutes and absorbance read at 450 nm in a FLUOstar Omega Microplate 
Reader (BMG Labtech, Offenburg, Germany).  All samples were assayed in triplicate and 
results expressed as U/mg protein. 
 
 
Figure 2.18.  Scheme of the Superoxide Dismutase Assay (Cayman Chemical Company, Kit 
insert). 
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2.7.7.2. Catalase 
Catalase (CAT) is an ubiquitous antioxidant enzyme present in most aerobic cells and is 
involved in the detoxification of H2O2 by catalysing the conversion of two H2O2 molecules to 
oxygen and two molecules of water.  The protocol by Ellerby and Bredesen was adapted for 
use in a 96 well plate (Ellerby and Bredesen, 2000).  In a 96 well clear UV plate, 5 µl diluted 
sample and 170 µl buffer (50 mM potassium phosphate, pH 7.0) was added and 0.1% H2O2 
added to initiate the reaction.  The linear decline in absorbance was monitored at 240 nm 
every 30 seconds for five minutes in a FLUOstar Omega Microplate Reader (BMG Labtech, 
Offenburg, Germany).  Liver and heart (cytosolic fraction) homogenates, prepared as 
described in section 2.7.5 and stored at -80°C, were thawed on ice.  Each sample was 
assayed in triplicate and catalase activity (µmole/min/µg protein) determined using the molar 
extinction coefficient of 43.6 M-1 cm-1. 
 
2.7.7.3. Glutathione Peroxidase 
Glutathione peroxidase (GPx) protects cells from oxidative damage by catalysing the 
reduction of hydroperoxidases (including H2O2) by reduced glutathione.  The Glutathione 
Peroxidase Assay Kit (703102) by Cayman Chemical Company (Ann Arbor, MI, USA) was 
used to measure GPx activity.  The assay kit measured the enzymatic activity indirectly by a 
coupled reaction with glutathione reductase (GR).  The oxidised glutathione (GSSG) produced 
by reduction of hydroperoxide by GPx, is recycled to its reduced state by GR and NADPH, 
according to the reactions in figure 2.19. 
 
 
Figure 2.19. Reactions used to determine GPx activity in the Cayman Chemical Company 
Assay Kit. 
 
Heart (cytosolic fraction) homogenates, prepared as described in section 2.7.5 and stored at 
-80°C, were thawed on ice.  All samples were diluted in sample buffer (50 mM Tris-HCl, pH 
7.6) as necessary and assayed in triplicate in a 96 well plate and the decrease in absorbance 
at 340 nm was read in a FLUOstar Omega Microplate Reader (BMG Labtech, Offenburg, 
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Germany) over five minutes and bovine erythrocyte GPx served as positive control.  
Background wells were free from bovine erythrocyte GPx or sample.  GPx activity 
(µmole/min/mg protein) was calculated using the extinction coefficient of 0.00622 µM-1 cm-1. 
 
2.7.7.4. Lipid Peroxidation 
Concentrations of conjugated dienes (CD) and thiobarbituric acid reactive substances 
(TBARS) were kindly analysed by Dr D Blackhurst (Division of Chemical Pathology, University 
of Cape Town, Cape Town, South Africa).  CD and TBARS were measured by 
spectrophotometric methods using a Labsystems Multiskan MS Analyser (AEC Amersham 
Co., South Africa).  Concentrations were calculated using the appropriate molar extinction 
coefficients and standards. CD were measured at 234 nm after appropriate dilution in 
cyclohexane (Spectrosol) as previously described (Esterbauer et al., 1989). After mixing the 
serum samples with cyclohexane, separation was enhanced by centrifugation (14000 × g for 
10 min at 10°C).  Values were expressed in μmol/l of serum. 
Thiobarbituric Acid Reactive Substances (TBARS) is a well-established method for the 
determination of lipid peroxidation, which serves as an indicator of oxidative stress and were 
measured according to the method of Jentzsch et al (1996).  Samples (200 µl) were mixed 
with 10 µl butylated hydroxytoluene (BHT) (Fluka Chemie, Switzerland) in ethanol (Merck 
Chemicals, South Africa) and orthophosphoric acid (Sigma) buffer at pH 3.6 and vortexed.  
TBA (Sigma) reagent (25 µl) was added and vortexed again. After incubation at 90°C for 45 
minutes in a water bath, the reaction was terminated by placing tubes on ice. TBARS were 
extracted with n-butanol, saturated NaCl (50 µl) added and the mixture centrifuged at 12000 
rpm for 1 minute.  Absorbance was read at 532 nm and values were expressed in μmol/l of 
serum. 
Alternatively, the TBARS Assay Kit (10009055) by Cayman Chemical Company (Ann Arbor, 
MI, USA) was used in our own laboratories to monitor lipid peroxidation in serum samples.  
Malondialdehyde (MDA) is a product of lipid peroxidation and forms an adduct with 
thiobarbituric acid (TBA) under high temperatures (90-100°C) and acidic conditions (Fig 2.20).  
The MDA-TBA adduct was measured colourimetrically at 535 nm in a FLUOstar Omega 
Microplate Reader (BMG Labtech, Offenburg, Germany). 
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Figure 2.20.  Formation of the MDA-TBA Adduct under high temperatures and acidic 
conditions in the Cayman Chemical Company TBARS Assay Kit. 
 
2.7.8. Inflammatory Markers 
Rat serum samples were analysed for TNF-α, IL-6 and CRP on the Bio-Rad Bio-Plex 200 
(Hercules, CA, USA) instrument by the Centre for Proteomic & Genomic Research (CPGR, 
Cape Town, South Africa).  Samples were assayed using the R&D SystemsTM (Minneapolis, 
MN, USA) Rat Premixed Multi-Analyte Kit for TNF-α and IL-6 and the ProcartaPlexTM 
(eBioscience, San Diego, CA, USA) Rat Multiplex Immunoassay kit for CRP.  Cytokine data 
was analysed using the Bio-Plex Manager 6.1 software.  Three multi-analyte plates (for TNF-
α and IL-6) and CRP simplex plates were run to cover all serum samples and a standard curve 
was generated for each analyte on each plate.  All standard curves were optimized by the 
software by identifying outliers that demonstrate poor standard curve recovery, poor intra-
assay percentage coefficient of variation (%CV) and saturation.   
 
2.7.9. Serum Lipids 
Serum total cholesterol (TC), triglycerides (TG) and phospholipid (PL) concentrations were 
kindly analysed by Dr D Blackhurst (Division of Chemical Pathology, University of Cape Town, 
Cape Town, South Africa). TC, TG and PL concentrations were determined by using 
enzymatic colorimetric kits (WAKO Chemicals, Germany) with a Labsystems Multiskan MS 
analyzer (AEC Amersham Co., South Africa).  TC were determined by pipetting 3 µl of the 
blank (saline), standard or sample into wells of a 96 well plate and adding 300 µl of colour 
solution to each well.  After mixing, the plate was incubated for five minutes at 37°C and 
absorbance read at 600 nm.  TG were determined by pipetting 4 µl blank (saline), standard 
(multi-lipid calibrator) or sample into the wells of a 96 well plate and adding 90 µl of Colour A.  
After mixing, the plate was incubated at 37°C for five minutes and absorbance measured at 
600 nm.  This measurement served as sample blank.  Following initial measurement, 30 µl of 
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Colour B was added to each well.  After mixing, the plate was incubated at 37°C for five 
minutes and absorbance measured at 600 nm.  Final absorbance was determined by 
subtracting the first measurement from the second measurement.  The TG concentration of 
samples was determined using the multi-lipid calibrator’s concentration and absorbance 
values from the standard (calibration) curve.  Phospholipids were determined by pipetting 3 µl 
blank (deiH2O), standard or sample into the wells of a 96 well plate and adding 300 µl Colour 
reagent solution to each well.  After mixing, the plate was incubated at 37°C for 10 minutes 
and absorbance measured at 600 nm.  Values for TC, TG and PL were expressed in mmol/l 
of serum. 
 
2.7.10. Statistical Analysis 
Data were analysed using GraphPad Prism® 5 software (GraphPad Software, San Diego, CA, 
USA).  Data were statistically analysed by means of one-way analysis of variance, followed 
by the Bonferroni post-test.  Differences with a p-value < 0.05 were considered statistically 
significant. A statistician at the Biostatistics Unit, Centre for Evidence Based Health Care, 
Faculty of Medicine and Health Sciences, Stellenbosch University, was consulted.   
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CHAPTER 3: RESULTS 
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3.1. Soluble Solids, Total Polyphenols and Flavonoid Content Determinations of 
Rooibos 
Unfermented rooibos had a significantly higher soluble solid content and total polyphenolic 
content than fermented rooibos (Soluble solids: RUF 4.6 ± 0.40 mg/ml; RF 3.5 ± 0.22 mg/ml, 
total polyphenolic content: RUF 0.23 ± 0.03 mg gallic acid/mg soluble solids; RF 0.16 ± 0.01 
mg gallic acid/mg soluble solids).  The daily total phenolic intake of the unfermented rooibos 
treatment groups (2% RUF and 2% RUF and 5 mg/kg bw/day nicotine co-treatment) were also 
significantly higher than that of the fermented rooibos treatment groups (2% RF and 2% RF 
and 5 mg/kg bw/day nicotine co-treatment) (Table 3.1). 
Fermented rooibos had a significantly higher flavonol content (0.36 ± 0.02 mg quercetin 
equivalents/mg soluble solids) than unfermented rooibos (0.18 ± 0.02 mg quercetin 
equivalents/mg soluble solids).  The daily flavonol intake of the fermented rooibos treatment 
groups were also significantly higher than that of the unfermented rooibos treatment groups 
(Table 3.2).  Unfermented rooibos had a significantly higher flavanol content (0.10 ± 0.01 mg 
catechin equivalents/mg soluble solids) than fermented rooibos (0.05 ± 0.00 mg catechin 
equivalents/mg soluble solids).  The daily flavanol intake of the unfermented rooibos treatment 
groups were also significantly higher than that of the fermented rooibos treatment groups 
(Table 3.3). 
Values of known flavonoid compounds, as determined by HPLC analysis, is given in table 3.4 
(fermented rooibos) and table 3.5 (unfermented rooibos). 
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Table 3.1. Soluble solid and total polyphenolic content of 2% fermented rooibos and 2% 
unfermented rooibos. 
 Soluble 
solids 
(mg/ml) 
Total 
phenolic 
content (mg 
gallic 
acid/mg 
soluble 
solids) 
Daily total 
phenolic 
intake (mg 
gallic acid 
equivalents/
day / 100g 
BW) 
 Daily total 
phenolic 
intake (mg 
gallic acid 
equivalents/
day / 100g 
BW) 
2% RF 3.5 ± 0.22 0.16 ± 0.01 5.17 ± 0.28 NRF 4.86 ± 0.31 
2% RUF 4.6 ± 0.40# 0.23 ± 0.03# 9.43 ± 0.46# NRUF 8.07 ± 0.26# 
BW (Body Weight); NRF (Nicotine 5 mg/kg bw/day + 2% Fermented Rooibos Co-treatment); 
NRUF (Nicotine 5 mg/kg bw/day + 2% Unfermented Rooibos Co-treatment); # p<0.05 vs 2% 
fermented rooibos treatment groups; n = 6. 
 
Table 3.2. Flavonol content of 2% fermented and 2% unfermented rooibos. 
 Flavonol 
content (mg 
quercetin 
equivalents/m
g soluble 
solids) 
Daily flavonol 
intake (mg 
quercetin 
equivalents/ 
day/ 100g BW) 
 Daily flavonol 
intake (mg 
quercetin 
equivalents/ 
day/ 100g BW) 
2% RF 0.36 ± 0.02@ 1.11 ± 0.06@ NRF 1.04 ± 0.07@ 
2% RUF 0.18 ± 0.02 0.74 ± 0.04 NRUF 0.63 ± 0.02 
BW (Body Weight); NRF (Nicotine 5 mg/kg bw/day + 2% Fermented Rooibos Co-treatment); 
NRUF (Nicotine 5 mg/kg bw/day + 2% Unfermented Rooibos Co-treatment); @ p<0.05 vs 2% 
unfermented rooibos treatment groups; n = 6. 
 
Table 3.3. Flavanol content of 2% fermented and 2% unfermented rooibos. 
 Flavanol content 
(mg catechin 
equivalents/mg 
soluble solids) 
Daily flavanol 
intake (mg 
catechin 
equivalents/ day/ 
100g BW)  
 Daily flavanol 
intake (mg 
catechin 
equivalents/ day/ 
100g BW) 
2% RF 0.05 ± 0.00 0.10 ± 0.01 NRF 0.09 ± 0.01 
2% RUF 0.10 ± 0.01# 0.37 ± 0.02# NRUF 0.32 ± 0.01# 
BW (Body Weight); NRF (Nicotine 5 mg/kg bw/day + 2% Fermented Rooibos Co-treatment); 
NRUF (Nicotine 5 mg/kg bw/day + 2% Unfermented Rooibos Co-treatment); # p<0.05 vs 2% 
fermented rooibos treatment groups; n = 6. 
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Table 3.4. HPLC quantification of flavonoids in 2% fermented rooibos consumed by rats. 
 2% RF   
 Concentration (µg/ml) % of Soluble 
Solids 
Daily intake 
(mg/100 g BW) 
Phenylpyruvic acid-2-O-
glucoside (PPAG) 
13.42 ± 0.00 0.391 ± 0.03 0.124 ± 0.01 
Aspalathin 7.57 ± 0.00 0.221 ± 0.01 0.070 ± 0.01 
Nothofagin 1.76 ± 0.00  0.051 ± 0.01 0.016 ± 0.00 
Isoorientin 31.99 ± 0.00  0.933 ± 0.06 0.295 ± 0.02 
Orientin 28.86 ± 0.00 0.842 ± 0.05 0.266 ± 0.01 
Ferulic acid 1.87 ± 0.00 0.055 ± 0.01 0.017 ± 0.00 
Quercetin-3-
robinobioside 
19.27 ± 0.00 0.562 ± 0.04 
 
0.178 ± 0.01 
Vitexin 5.65 ± 0.00 0.165 ± 0.01 0.052 ± 0.01 
Hyperoside 5.40 ± 0.00 0.156 ± 0.01 0.050 ± 0.01 
Rutin 1.60 ± 0.00 0.047 ± 0.01 0.015 ± 0.00 
Isovitexin 5.76 ± 0.00 0.168 ± 0.01 0.053 ± 0.01 
Isoquercitrin 3.64 ± 0.00 0.106 ± 0.01 0.034 ± 0.01 
Luteolin-7-glucoside 0.83 ± 0.00 0.024 ± 0.01 0.008 ± 0.00 
BW (body weight), RF (fermented rooibos treatment group); n = 5-6.  
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Table 3.5. HPLC quantification of flavonoids in 2% unfermented rooibos consumed by rats. 
 2% RUF   
 Concentration 
(µg/ml) 
% of Soluble 
Solids 
Daily intake (mg/100 g 
BW) 
PPAG 15.93 ± 0.00  0.361 ± 0.04 0.148 ± 0.01 
Aspalathin 392.96 ± 0.00  8.907 ± 1.05 3.645 ± 0.18 
Nothofagin 57.85 ± 0.00  1.311 ± 0.15 0.537 ± 0.03 
Isoorientin 65.22 ± 0.00 1.478 ± 0.17 0.605 ± 0.03 
Orientin 49.95 ± 0.00 1.132 ± 0.13 0.463 ± 0.02 
Ferulic acid not detected 
Quercetin-3-
robinobioside 
17.46 ± 0.00  0.395 ± 0.05 
 
0.162 ± 0.01 
Vitexin 7.42 ± 0.00  0.168 ± 0.02 0.069 ± 0.01 
Hyperoside 2.92 ± 0.00 0.066 ± 0.01 0.027 ± 0.01 
Rutin 13.82 ± 0.00  0.313 ± 0.04 0.128 ± 0.01 
Isovitexin 9.88 ± 0.00  0.224 ± 0.03 0.091 ± 0.01 
Isoquercitrin 4.40 ± 0.00  0.099 ± 0.01 0.041 ± 0.01 
Luteolin-7-glucoside 1.40 ± 0.00 0.031 ± 0.01 
 
0.013 ± 0.00 
PPAG (Phenylpyruvic acid-2-O-glucoside), BW (body weight), RUF (unfermented rooibos 
treatment group); n = 5-6. 
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3.2. In vivo and Ex vivo Investigations: Pilot Study 
3.2.1. Introduction 
Before the main in vivo and ex vivo studies were undertaken, an optimal vascular injury-
inducing concentration of nicotine had to be established in our experimental setting.  Based 
on literature, 1 mg/kg bw/day and 2 mg/kg bw/day (Benowitz and Jacob, 1999; Balakumar et 
al., 2008b) nicotine were chosen for the concentration-response pilot studies, and compared 
to saline vehicle control over a six week treatment period.  Nicotine and saline were 
administered via the subcutaneous route.   
 
3.2.2. Specific Aims 
The pilot study aimed to determine an optimal vascular injury-inducing concentration in an in 
vivo Wistar rat model by assessment of the following endpoints: 
3.2.2.1. Biometric Measurements and Fluid Intake 
Biometric data, including start and end body weights, as well as weekly fluid intakes were 
recorded. 
3.2.2.2. Blood Pressure 
Blood pressure was non-invasively measured by means of the CODATM tail-cuff method. 
3.2.2.3. Vascular Function 
Vascular relaxation responses were determined in aortic rings by means of isometric tension 
studies.  
3.2.2.4. Lipid Peroxidation 
Lipid peroxidation was measured in serum samples by means of the TBARS assay.  
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3.2.3. Results 
3.2.3.1. Biometric Measurements and Fluid Intake 
Nicotine treatments did not result in a significant difference in the mean weight gain when 
compared to saline controls (vehicle control: 55.83 ± 4.19 g; 1 mg/kg bw/day nicotine: 55 ± 
3.62 g; 2 mg/kg bw/day 41.68 ± 9.52 g) (Fig 3.1).  Nicotine resulted in a significant decrease 
in mean daily fluid intake in both 1 mg/kg bw/day and 2 mg/kg bw/day when compared to 
saline vehicle control (vehicle control: 32.43 ± 1.452 ml; 1 mg/kg bw/day nicotine: 26 ± 0.71 
ml; 2 mg/kg bw/day nicotine 23.89 ± 0.78 ml) (Fig 3.2). 
 
 
Figure 3.1. Mean weight gain over the six week treatment period.  No significant differences 
were found (n = 5 per group). 
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Figure 3.2. Mean daily fluid intake over the six week treatment period.  Both 1 mg/kg bw/day 
and 2 mg/kg bw/day nicotine treatment resulted in significantly lower fluid (water) intake when 
compared to the saline vehicle control group. * p<0.05 vs control (n = 5 per group). 
 
3.2.3.2. Blood Pressure 
Blood pressure measurements by means of the non-invasive tail-cuff method did not 
demonstrate any significant changes at the end of the six week treatment period in mean 
systolic (Fig 3.3 A), mean diastolic (Fig 3.3 B) or mean arterial blood pressure (Fig 3.3 C) in 1 
mg/kg bw/day or 2 mg/kg bw/day nicotine treatment groups when compared to the saline 
vehicle control group (Table 3.6).   
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Table 3.6. Mean systolic, mean diastolic and mean arterial blood pressure in the saline vehicle 
control, 1mg/kg bw/day and 2mg/kg bw/day nicotine treated groups. 
 Mean Systolic Pressure Mean Diastolic Pressure Mean Arterial Pressure 
Saline Vehicle Control 161.10 ± 7.28 mmHg 118.10 ± 6.76 mmHg 134.20 ± 4.96 mmHg 
1 mg/kg bw/day nicotine 147.10 ± 8.27 mmHg 105.90 ± 8.20 mmHg 120.70 ± 8.64 mmHg 
2 mg/kg bw/day nicotine 148.30 ±9.37 mmHg 113.40 ± 10.25 mmHg 124.70 ± 9.93 mmHg 
 
A     B  
C  
Figure 3.3. The effects of administration of 1 mg/kg bw/day and 2 mg/kg bw/day nicotine on 
blood pressure over a six week treatment period.  The administration of 1 mg/kg bw/day and 
2 mg/kg bw/day nicotine resulted in no significant changes in A) mean systolic blood pressure; 
B) mean diastolic blood pressure and C) mean arterial pressure when compared to saline 
vehicle control rats (n = 5 per group). 
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3.2.3.3. Vascular Function by means of Isometric Tension Studies in Aortic Rings 
Vascular function was determined by means of isometric tension studies in aortic rings.  After 
contraction was induced by 100 nM Phe, ACh was added in a cumulative manner in order to 
determine endothelium-dependent relaxation.  Cumulative ACh relaxation demonstrated no 
significant differences between the 1 mg/kg bw/day and 2 mg/kg bw/day nicotine treatment 
groups, or the saline vehicle control group (Fig 3.4). 
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Figure 3.4. The administration of 1 mg/kg bw/day and 2 mg/kg bw/day nicotine over a six 
week treatment period did not result in significant effects on aortic ring relaxation when 
compared to saline vehicle control aortic rings (n = 4-5 per group). 
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3.2.3.4. Lipid Peroxidation: TBARS 
Lipid peroxidation measurements, as determined by a standard TBARS assay kit showed no 
significant differences in MDA equivalents in the 1 mg/kg bw/day and 2 mg/kg bw/day nicotine 
treatment groups as compared to the vehicle control group (vehicle control: 6.95 ± 0.60 µM; 1 
mg/kg bw/day nicotine: 5.59 ± 0.71 µM; 2 mg/kg bw/day nicotine 5.93 ± 0.27 µM) (Fig 3.5). 
 
 
Figure 3.5. There were no significant differences in serum lipid peroxidation measurements 
(TBARS assay) between 1 mg/kg bw/day and 2 mg/kg bw/day nicotine treated rats as 
compared to saline vehicle control rats (n = 5 per group). 
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3.2.4. Summary of Pilot Study Results 
A six week treatment period with 1 mg/kg bw/day and 2 mg/kg bw/day nicotine did not result 
in any significant differences in blood pressure, vascular function or lipid peroxidation when 
compared to the saline vehicle control.  Mean body weights at the end of the treatment period 
were not significantly influenced.  Mean daily fluid intake was the only endpoint that was 
significantly affected by treatment with 1 mg/kg bw/day and 2 mg/kg bw/day nicotine.  
Administration of nicotine at both concentrations resulted in a significant reduction in fluid 
intake when compared to the saline vehicle control. 
Based on these results, it was concluded that six weeks treatment with 1 mg/kg bw/day or 2 
mg/kg bw/day nicotine did not induce sufficient injury in our experimental setting. As a result 
of these findings, it was decided to perform the main study by treating the rats with a higher 
nicotine concentration (5 mg/kg bw/day) as previously used in another study (Zimmerman and 
McGeachie, 1985). 
 
  
Stellenbosch University  https://scholar.sun.ac.za
 78 
 
3.3. In vivo and Ex vivo Investigations: Main Study 
3.3.1. Introduction 
The modulating capabilities of rooibos (fermented and unfermented) and melatonin in a model 
of nicotine-induced vascular injury was assessed in vivo and ex vivo according to the specific 
aims listed in section 3.3.2. 
 
3.3.2. Specific Aims 
3.3.2.1. Biometric Measurements and Fluid Intake 
Biometric measurements, including mean body weights, mean organ weights (heart and liver), 
as well as the mean weekly fluid intake were recorded. 
3.3.2.2. Blood Pressure 
Blood pressure was measured non-invasively by means of the CODATM tail-cuff method. 
3.3.2.3. Vascular Function 
Vascular contraction / relaxation responses were determined in aortic rings by means of 
isometric tension studies.  In a separate set of experiments, the cellular effects of nicotine and 
rooibos were further investigated utilising a cultured rat aortic endothelial cell model. 
3.3.2.4. Antioxidant Enzyme Activity and Oxidative Stress Status 
The antioxidant enxyme activity and oxidative stress status was measured by determining 
SOD activity and CAT activity in heart and liver tissue homogenates and GPx activity in heart 
tissue homogenates.  Lipid peroxidation was determined in serum samples. 
3.3.2.5. Inflammatory Markers 
Serum samples were analysed for TNF-α, IL-6 and CRP levels. 
3.3.2.6. Serum Lipid Measurements 
Total cholesterol, triglycerides and phospholipid concentrations were determined in serum 
samples. 
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3.3.3. Results 
For the main in vivo and ex vivo study a total of 90 rats were divided into nine groups (n = 10 
per group), namely nicotine and saline vehicle control, as well as nicotine co-treated with either 
fermented rooibos, unfermented rooibos or melatonin, and groups receiving water, rooibos 
(fermented or unfermented) or melatonin.  The groups received the respective treatments for 
six weeks and the following data were obtained.  The abbreviations defined in Table 3.7 are 
frequently used to describe treatment groups. 
 
Table 3.7. Abbreviations used for treatment groups 
Abbreviation Treatment Group 
Veh Control Saline Vehicle Control (subcutaneous administration) 
for nicotine treated groups (nicotine, NRF, NRUF, NMel) 
Water Control Drinking Control (tap water) for rooibos and melatonin 
groups 
Nicotine Nicotine 5 mg/kg bw/day (subcutaneous administration) 
RF Rooibos Fermented 2% 
RUF Rooibos Unfermented 2% 
Mel Melatonin 4 mg/kg bw/day 
NRF Nicotine 5 mg/kg bw/day + Rooibos Fermented 2% 
NRUF Nicotine 5 mg/kg bw/day + Rooibos Unfermented 2% 
NMel Nicotine 5 mg/kg bw/day + Melatonin 4 mg/kg bw/day 
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3.3.3.1. Biometric Measurements and Fluid Intake 
3.3.3.1.1. Mean Body Weight Gain 
The veh control (53.83 ± 10.50 g), water control (93.82 ± 9.97 g), RF (96.4 ± 6.59 g), RUF 
(93.24 ± 6.97 g) and Mel (56.17 ± 10.32 g) groups showed a significant increase in mean body 
weight gain over the six week treatment period when compared to the nicotine (4.71 ± 5.68 
g), NRF (8.46 ± 3.45 g), NRUF (18.09 ± 8.89 g) and NMel (-7.28 ± 5.35 g) treatment groups.  
In addition, the water control, RF and RUF groups showed a significant increase in weight 
gain over the six week treatment period when compared to the veh control and Mel groups 
(Fig 3.6). 
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Figure 3.6. Mean weight gain at the end of the six week treatment period.  # p<0.05 vs 
nicotine; $ p< 0.05 vs NRF; @ p<0.05 vs NRUF; & p<0.05 vs NMel; ! p<0.05 vs veh control; * 
p<0.05 vs Mel (n = 10 per group). 
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3.3.3.1.2. Mean Relative Organ Weights 
The ratio of the mean heart weight/body weight and mean liver weight/body weight were 
determined for all treatment groups.  The mean heart weight/body weight ratio was 
significantly increased in the nicotine group (0.308 ± 0.01) when compared to the water control 
(0.266 ± 0.006), RF (0.273 ± 0.01) and NMel (0.272 ± 0.01) groups; however, there was no 
difference compared to the veh control group.  The mean heart weight/body weight ratio was 
also significantly increased in the NRUF group (0.300 ± 0.01) when compared to the water 
control group (Fig 3.7). 
The mean liver weight/body weight ratio was significantly increased in the nicotine group 
(3.368 ± 0.06) when compared to the water control (2.943 ± 0.06), RF (2.941 ± 0.04), RUF 
(2.865 ± 0.06), Mel (2.789 ± 0.07), NRF (3.010 ± 0.08), NRUF (3.003 ± 0.07) and NMel groups 
(2.907 ± 0.07); however, there was no difference between the nicotine group and its veh 
control group.  The mean liver weight/body weight ratio of the vehicle control group (3.180 ± 
0.07) was significantly increased when compared to the RUF and Mel groups. 
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Figure 3.7. Mean heart weight/body weight ratio.  $ p<0.05 vs water control; % p<0.05 vs RF; 
& p<0.05 vs NMel (n = 10 per group). 
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Figure 3.8. Mean liver weight/body weight ratio.  $ p<0.05 vs RUF; % p<0.05 vs Mel; # p<0.05 
vs RF; * p<0.05 vs water control; & p<0.05 vs NRF; ! p<0.05 vs NRUF; ? p<0.05 vs NMel (n = 
10 per group). 
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3.3.3.1.3. Fluid Intake 
Rats were caged individually and fluid intake was measured weekly (water, fermented rooibos, 
unfermented rooibos) or daily (melatonin).  Figure 3.9 shows the mean daily fluid intake (ml) 
of each treatment group.  The mean daily fluid intake of the water control (26.09 ± 0.81 ml), 
nicotine (25.38 ± 1.14 ml), NRF (25.33 ± 1.92 ml) and NRUF (23.99 ± 0.87 ml) groups were 
significantly reduced when compared to the veh control (34.87 ± 2.67 ml), RF (35.17 ± 1.91 
ml), RUF (35.81 ± 1.45 ml), Mel (36.63 ± 1.74 ml) and NMel (35.79 ± 1.75 ml) groups. 
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Figure 3.9. Mean daily fluid intakes of all treatment groups.  @ p<0.05 vs veh control; # 
p<0.05 vs RF; $ p<0.05 vs RUF; % p<0.05 vs Mel; * p<0.05 vs NMel (n = 10 per group).  
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3.3.3.2. Blood Pressure 
Blood pressure was non-invasively measured by means of the CODATM tail-cuff system.  Rats 
were acclimatised to the apparatus for one week prior to measurements.  Results reflect blood 
pressure at the end of the six week treatment period.  However, due to noise levels and 
interruptions attributed to building works taking place in the Central Animal Housing Unit of 
the Faculty of Medicine and Health Sciences, blood pressure readings could not be completed 
for all groups. 
In the assessed groups it was found that mean systolic pressure was significantly increased 
in the water control (145.1 ± 1.48 mmHg), nicotine (145.0 ± 3.02 mmHg) and RUF (147.6 ± 
3.54 mmHg) groups when compared to the veh control group (122.4 ±  3.47 mmHg) (Fig 3.10).  
Nicotine treatment also significantly increased mean diastolic pressure (114.8 ± 1.99 mmHg) 
when compared to the veh control (100.3 ± 1.93 mmHg) and NMel (84.21 ± 2.28 mmHg) 
groups and mean arterial pressure (116.3 ± 1.93 mmHg) when compared to the veh control 
group (100.2 ± 1.83 mmHg) and NMel (100.7 ± 1.80 mmHg) groups (Fig 3.11 and Fig 3.12). 
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Figure 3.10. Mean systolic blood pressure was significantly increased in the water control, 
nicotine and RUF groups when compared to the veh control group; * p<0.05 vs veh control (n 
= 4-8 per group). 
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Figure 3.11. Mean diastolic blood pressure was significantly increased in the nicotine group 
when compared to the veh control and NMel groups; * p<0.05 vs veh control; # p<0.05 vs 
NMel (n = 4-8 per group). 
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Figure 3.12. The mean arterial pressure in the nicotine group was significantly increased when 
compared to the veh control and NMel groups; * p<0.05 vs vehicle control; # p<0.05 vs NMel 
(n = 4-8 per group). 
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3.3.3.3. Vascular Function 
3.3.3.3.1. Vascular Contraction / Relaxation Function Measurements by means of 
Isometric Tension Studies in Aortic Rings 
The vascular function of all treatment groups was assessed by means of aortic ring isometric 
tension studies.  The experimental protocol made use of cumulative additions of Phe and ACh 
to test the functionality of the endothelium. 
Aortic rings from the nicotine treatment rats showed a significant pro-contractile response to 
Phe administration when compared to the saline vehicle control (Fig 3.13), but had no 
significant effect on relaxation (Fig 3.14).  Aortic rings from Mel treatment rats showed a 
significant anti-contractile response to Phe administration when compared to the water control, 
RF and RUF treatment groups (Fig 3.15).  Aortic rings from Mel, RF and RUF treatment rats 
showed a significant pro-relaxation response to ACh administration when compared to the 
water control group (Fig 3.16). 
Aortic rings from NMel, NRF and NRUF treatment rats showed a significant anti-contractile 
response to Phe administration when compared to the nicotine treatment group.  Additionally, 
aortic rings from NMel treatment rats also showed a significant anti-contractile response to 
Phe administration when compared to the NRF and NRUF treatment groups (Fig 3.17).  Aortic 
rings from NMel and NRF treatment rats showed a significant pro-relaxation response to Ach 
administration when compared to the nicotine and NRUF groups.  Aortic rings from the NMel 
treatment rats also showed a significant pro-relaxation response to ACh administration when 
compared to the NRUF group (Fig 3.18). 
  
Stellenbosch University  https://scholar.sun.ac.za
 92 
 
 
Figure 3.13. Graph indicating the contractile responses of aortic rings harvested from the veh 
control and nicotine treated rats following cumulative Phe administration (* p<0.05 nicotine vs 
veh control) (n = 6-9 per group). 
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Figure 3.14. Graph indicating the relaxation response of aortic rings harvested from veh 
control and nicotine treated rats following cumulative ACh administration (n = 6-9 per group). 
  
Stellenbosch University  https://scholar.sun.ac.za
 94 
 
 
Figure 3.15. Graph indicating the contractile responses of aortic rings from Mel, RF, RUF and 
water control animals following cumulative Phe administration (* p<0.05 Mel vs RF, RUF and 
water control) (n = 8-10 per group). 
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Figure 3.16. Graph indicating the relaxation response of aortic rings harvested from Mel, RF, 
RUF and water control treated rats following cumulative ACh administration. (* p <0.05 water 
control vs Mel, RF and RUF) (n = 7-10 per group). 
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Figure 3.17. Graph indicating the contractile responses of aortic rings harvested from nicotine, 
NMel, NRF and NRUF treated rats following cumulative Phe administration (* p<0.05 NMel vs 
NRF and NRUF; # p<0.05 NMel vs nicotine; $ p<0.05 NRF, NRUF vs nicotine) (n = 6-10 per 
group). 
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Figure 3.18. Graph indicating the relaxation response of aortic rings harvested from nicotine, 
NMel, NRF and NRUF treated rats following cumulative ACh administration (* p<0.05 NMel 
and NRF vs nicotine and NRUF) (n = 6-10 per group). 
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3.3.3.3.2. Additional in vitro Investigations 
3.3.3.3.2.1. The Effects of Nicotine on NO Production and Cell Viability under Baseline 
Conditions: Dose-response Investigations 
In separate in vitro investigations carried out on cultured rat aortic endothelial cells (AECs) the 
effect of 1 µM, 10 µM and 100 µM nicotine on NO production was determined after a 24 hour 
treatment period.  Treatment with 1 µM and 10 µM nicotine had no significant effect on NO 
production, while 100 µM nicotine showed significantly lower DAF-2/DA fluorescence 
compared to control (adjusted to 100%) and 1 µM nicotine (96.37 ± 4.24%), indicating a 
reduction in NO production (79.5  ± 2.98%; p<0.05) (Fig 3.19).   
In the dose-response investigations, 1 µM and 10 µM had no significant effects on cell viability 
over a 24 hour treatment period.  However, 100 µM nicotine showed a significant reduction in 
cell viability, as indicated by increased Annexin V fluorescence (162.2 ± 57.16%) (Fig 3.20) 
and increased PI fluorescence (177.2 ± 30.25%) compared to control (adjusted to 100%) (Fig 
3.21).  
Based on the fact that 100 µM nicotine treatment induced significant cell injury (reduced NO 
production and reduced cell viability), this concentration was chosen for further 
experimentation. 
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Figure 3.19. The effect of 1 µM, 10 µM and 100 µM nicotine on intracellular NO production as 
measured by DAF-2/DA fluorescence after a 24 hour treatment period.  100 µM nicotine 
significantly decreased NO levels after 24 hours.  $ p<0.05 vs Control; # p<0.05 vs 1 µM 
Nicotine (n = 4-10 per group). 
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Figure 3.20. The effect of 24 hour nicotine treatment on cell viability. % Change in apoptosis 
indicated by Annexin V fluorescence.  * p<0.05 vs Control (n = 4-8 per group). 
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Figure 3.21. The effect of 24 hour nicotine treatment on cell viability.  % Change in necrosis 
indicated by PI fluorescence.  * p<0.05 vs Control (n = 4-8 per group). 
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3.3.3.3.2.2. The Effects of Fermented Rooibos (RF) on NO Production and Cell Viability 
on Cultured Aortic Endothelial Cells (AECs) under Baseline Conditions: Dose-response 
Investigations 
The effects of 0.015 mg/ml; 0.0625 mg/ml; 0.125 mg/ml and 0.25 mg/ml fermented rooibos on 
NO production and cell viability (necrosis) were determined under baseline conditions in 
healthy cells after a 24 hour treatment period.   
Fermented rooibos (0.25 mg/ml) resulted in a significant reduction in NO production when 
compared to the control (81.68 ± 5.80%; p<0.05); however, treatment with 0.015 mg/ml, 
0.0625 mg/ml and 0.125 mg/ml RF exerted no detrimental effects on NO production compared 
to control (adjusted to 100%) (0.015 mg/ml: 98.39 ± 5.38%; 0.0625 mg/ml: 96.69 ± 8.06%; 
0.125 mg/ml: 90.42 ± 9.44%) (Fig 3.22). 
Fermented rooibos (0.125 mg/ml) resulted in a significant increase in necrosis as measured 
by PI fluorescence when compared to the control (adjusted to 100%) (140.7 ± 6.04%, p<0.05).  
0.015 mg/ml, 0.0625 mg/ml and 0.25 mg/ml fermented rooibos treatment had no effects on 
necrosis compared to control, as measured by PI fluorescence (0.015 mg/ml: 91.84 ± 19.63%; 
0.0625 mg/ml: 122.2 ± 19.36%; 116 ± 7.71%) (Fig 3.23). 
Based on these results, 0.015 mg/ml fermented rooibos was chosen as the concentration for 
further experimentation, since it did not result in a reduction in NO production and did not affect 
cell viability. 
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Figure 3.22. The effects of 0.015 mg/ml; 0.0625 mg/ml; 0.125 mg/ml and 0.25 mg/ml 
fermented rooibos on NO production as measured by DAF-2/DA fluorescence after a 24 hour 
treatment period.  $ p<0.05 vs Control; # p<0.05 vs 0.015 mg/ml RF (n = 6-8 per group). 
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Figure 3.23. The effect of 0.015 mg/ml; 0.0625 mg/ml; 0.125 mg/ml and 0.25 mg/ml fermented 
rooibos treatment over a 24 hour period on cell viability.  % Change in necrosis indicated by 
PI fluorescence.  $ p<0.05 vs control; # p<0.05 vs 0.015 mg/ml RF (n = 6-8 per group). 
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3.3.3.3.2.3. The Effects of RF Pre-treatment on NO Production and Cell Viability in 
Nicotine Treated AECs 
AECs were pre-treated for one hour with 0.015 mg/ml RF, followed by the addition of 100 µM 
nicotine for a further 24 hours.  Pre-treatment with 0.015 mg/ml RF was able to modestly, but 
significantly increase NO production in nicotine-injured cells compared to cells treated with 
nicotine only, as indicated by DAF-2/DA fluorescence (control: 100 %; 100 µM nicotine: 78.75 
± 4.65 %; 0.015 mg/ml RF: 98.39 ± 2.69 %; nicotine in combination with RF: 93.5 ± 4.01 %) 
(Fig 3.24). 
However, pre-treatment with 0.015 mg/ml fermented rooibos was not able to significantly 
reduce necrosis in nicotine-injured cells, as measured by PI fluorescence (Control 100%; 100 
µM nicotine: 152.6% ± 32.79%; 0.015 mg/ml rooibos fermented: 91.84% ± 19.63%; nicotine 
and rooibos fermented co-treatment: 133.8% ± 17.10%) (Fig 3.25).  
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Figure 3.24. The effects of fermented rooibos pre-treatment on NO as measured by DAF-
2/DA fluorescence.  * p<0.05 vs control; # p<0.05 vs 100 µM nicotine (n = 6-8 per group). 
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Figure 3.25. The effects of fermented rooibos pre-treatment on cell viability.  % Change in 
necrosis indicated by PI fluorescence.   $ p<0.05 when compared to control.  # p<0.05 when 
compared to 0.015 mg/ml RF.  * p<0.05 when compared to 0.015 mg/ml RF (n = 6-8 per 
group). 
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3.3.3.4. Antioxidant Enzyme Activity and Oxidative Stress Status Measurements 
3.3.3.4.1. Superoxide Dismutase (SOD) 
SOD activity was determined in heart tissue homogenates (cytosolic and mitochondrial 
fractions) and liver tissue homogenates, where one unit (U) of SOD is defined as the amount 
of enzyme needed to exhibit 50% dismutation of the superoxide radical.  SOD activity was 
significantly increased in the RF treatment group (73.55 ± 4.89 U/mg protein) of the heart 
cytosolic fraction, when compared to the water control (57.63 ± 5.26 U/mg protein), RUF 
(57.57 ± 2.02 U/mg protein), Mel (50.71 ± 4.39 U/mg protein), NRF (49.72 ± 4.19 U/mg protein) 
and NMel (53.65 ± 2.35 U/mg protein) groups (Fig 3.26).  SOD activity was significantly 
increased in the water control (5.640 ± 0.76 U/mg protein), Mel (5.541 ± 0.63 U/mg protein), 
NRF (5.445 ± 0.63 U/mg protein) and NRUF (5.766 ± 0.79 U/mg protein) treatment groups of 
the heart mitochondrial fraction, when compared to the RF group.  SOD activity was also 
significantly increased in the NRUF group, when compared to the veh control group (3.557 ± 
0.64 U/mg protein) (Fig 3.27). 
SOD activity was significantly increased in the veh control (155.3 ± 6.723 U/mg protein) RF 
(192.0 ± 21.06 U/mg protein), RUF (182.7 ± 20.38 U/mg protein), NRF (160.7 ± 6.41 U/mg 
protein) and NMel (180.8 ± 8.96 U/mg protein) treatment groups of liver tissue homogenates, 
when compared to the nicotine group (121.4 ± 14.69 U/mg protein).  SOD activity of the RF 
group was also significantly increased, when compared to the water control (135.5 ± 5.03 
U/mg protein) and Mel (133.8 ± 10.41 U/mg protein) groups (Fig 3.28). 
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Figure 3.26. SOD activity in heart cytosolic fractions.  # p<0.05 vs water control; $ p<0.05 vs 
RUF; % p<0.05 vs Mel; & p<0.05 vs NRF; * p<0.05 vs NMel (n = 10 per group). 
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Figure 3.27. SOD activity in the heart mitochondrial fractions.  * p<0.05 vs RF, # p<0.05 vs 
veh control (n = 10 per group). 
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Figure 3.28. SOD activity in liver tissue homogenates; # p<0.05 vs water control, $ p<0.05 vs 
Mel, * p<0.05 vs nicotine (n = 10 per group). 
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3.3.3.4.2. Catalase (CAT) 
CAT activity was determined in heart tissue homogenates (cytosolic fraction) and liver tissue 
homogenates.  CAT activity was significantly reduced in the nicotine treatment group (608.2 
± 59.75 µmole/min/µg) of heart tissue homogenates, when compared to the veh control (1109 
± 174.6  µmole/min/µg), RF (878.2 ± 83.69 µmole/min/µg), Mel (997.2 ± 173.6 µmole/min/µg), 
NRUF (819.1 ± 108.4 µmole/min/µg) and NMel (808.7 ± 71.89 µmole/min/µg) groups (Fig 
3.29).   
In liver tissue homogenates, CAT activity was significantly reduced in the nicotine treatment 
group (295.8 ± 76.72 µmole/min/µg) when compared to the vehicle control (868.3 ± 138.4 
µmole/min/µg), Mel (597.7 ± 98.19 µmole/min/µg), NRF (727.3 ± 158.6 µmole/min/µg) and 
NMel (565.8 ± 86.96 µmole/min/µg) groups.  CAT activity was also significantly increased in 
the vehicle control group when compared to the water control group (427.2 ± 51.42 
µmole/min/µg) (Fig 3.30). 
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Figure 3.29. CAT activity in the heart cytosolic fractions.  * p<0.05 vs nicotine (n = 9-10 per 
group). 
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Figure 3.30. CAT activity in liver tissue homogenates.  * p<0.05 vs nicotine, # p<0.05 vs water 
control (n = 9-10 per group). 
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3.3.3.4.3. Glutathione Peroxidase (GPx) 
GPx activity was determined in heart tissue homogenates, but did not result in any significant 
differences between treatment groups (Fig 3.31). 
 
 
Figure 3.31. GPx activity in heart cytosolic fractions (n = 10 per group). 
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3.3.3.4.4. Lipid Peroxidation 
Conjugated dienes (CD) and thiobarbituric acid reactive substances (TBARS) were 
determined in serum samples as measures of lipid peroxidation.  Analysis of CD did not result 
in any significant difference between treatment groups (Fig 3.32). 
TBARS levels were significantly increased in the nicotine treatment group (4.615 ± 0.31 µmol/l) 
when compared to the vehicle control (2.907 ± 0.23 µmol/l), water control (2.997 ± 0.26 µmol/l), 
RF (2.472 ± 0.26 µmol/l), RUF (3.350 ± 0.30 µmol/l), Mel (2.829 ± 0.28 µmol/l) and NMel 
(3.411 ± 0.26 µmol/l) treatment groups (Fig 3.33).  TBARS levels were also significantly 
increased in the NRF (3.772 ± 0.27 µmol/l) and NRUF (3.707 ± 0.14 µmol/l) groups when 
compared to the RF group. 
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Figure 3.32. Serum CD levels in all treatment groups.  No significant differences were 
observed (n = 9-10 per group). 
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Figure 3.33. TBARS levels in serum of all treatment groups.  # p<0.05 vs RF; $ p<0.05 vs veh 
control; & p<0.05 vs water control; @ p<0.05 vs RUF; ! p<0.05 vs Mel; * p<0.05 vs NMel (n = 
10 per group). 
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3.3.3.5. Inflammatory Markers 
Serum samples were analysed for TNF-α, IL-6 and CRP.  TNF-α and IL-6 fell below the 
detectable range of the multi-analyte kit utilised, however, CRP levels could be determined.  
CRP levels were significantly decreased in the RUF (293.0 ± 46.8 pg/ml), Mel (257.5 ± 21.0 
pg/ml), NRUF (358.3 ± 29.3 pg/ml) and NMel (263.2 ± 58.3 pg/ml) groups, when compared to 
the veh control (620.4 ± 70.9 pg/ml), water control (774.5 ± 51.5 pg/ml), RF (653.1 ± 29.0 
pg/ml) and NRF (680.7 ± 88.5 pg/ml) groups.  Additionally, CRP levels in the nicotine treatment 
group (448.0 ± 69.9 pg/ml) were significantly decreased when compared to the water control 
group (Fig 3.34). 
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Figure 3.34. C-reactive protein levels in serum.  # p<0.05 vs RUF; ! p<0.05 vs Mel; & p<0.05 
vs NRUF; $ p<0.05 vs NMel; * p<0.05 vs nicotine (n = 8-10 per group). 
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3.3.3.6. Serum Lipids 
Total cholesterol (TC), phospholipid (PL) and triglycerides (TG) concentrations were 
determined in serum.  Analysis of TC and PL concentrations did not result in any significant 
differences (Fig 3.35 and Fig 3.36).  TG concentrations were significantly decreased in the 
nicotine (0.376 ± 0.05 mmol/l) group, when compared to the veh control (0.557 ± 0.07 mmol/l), 
water control (0.635 ± 0.06 mmol/l), RF (0.639 ± 0.07 mmol/l) and RUF (0.76 ± 0.08 mmol/l) 
treatment groups.  TG concentrations were also significantly decreased in the NMel (0.41 ± 
0.05 mmol/l) group, when compared to the RUF group (Fig 3.37). 
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Figure 3.35. Total cholesterol concentrations in serum.  No significant differences were 
observed (n = 10 per group). 
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Figure 3.36. Phospholipid concentrations in serum.  No significant differences were observed 
(n = 10 per group). 
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Figure 3.37. Triglyceride concentrations in serum.  # p<0.05 vs nicotine; * p<0.05 vs NMel (n 
= 10 per group). 
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CHAPTER 4: DISCUSSION 
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CVD is a leading cause of death globally (Mendis, 2011) and it is expected that the number of 
annual deaths due to CVD will escalate to 23.4 million by the year 2030 (WHO, 2009).  
Cigarette smoking is one of the most important risk factors of CVD, while nicotine, the addictive 
substance in tobacco, is implicated in the pathogenesis of atherosclerosis (Tsiara et al., 2003 
and Kilaru et al., 2001). The relative health of vascular endothelium is a critical determinant of 
future cardiovascular disease and is involved in many important functions, such as regulation 
of vascular tone and the synthesis and release of vasoactive substances, thus playing an 
important role in maintaining vascular homeostasis (Behrendt and Ganz, 2002).  NO can be 
considered one of the most important vasoactive substances and is a potent vasodilator 
(Mudau et al., 2012), in addition to possessing cardioprotective properties.  In this regard, two 
major enzymatic sources of NO, eNOS and nNOS, have previously been shown to have anti-
atherosclerotic actions (Liu and Haung, 2008). 
Endothelial dysfunction is an early precursor of atherosclerosis and its development is 
associated with a number of cardiovascular risk factors, including smoking (Cipollone et al., 
2007).  Endothelial dysfunction develops when the balance between the vasodilatory and 
vasoconstrictory state of blood vessels is disrupted, usually as a result of reduced NO 
bioavailability.  Oxidative stress can lead to a loss of vascular homeostasis and appears to be 
a major underlying mechanism of endothelial dysfunction.  If risk factors are sustained and 
early endothelial changes are not reversed, progression to atherosclerosis and CVD will follow 
(Mudau et al., 2012).  However, it has been shown that early endothelial changes, such as 
ED, are reversible (Hsueh et al., 2004).  Thus, it is important to identify therapeutic compounds 
capable of counteracting oxidative stress, reducing or reversing endothelial dysfunction, and 
restoring vascular homeostasis.   
Nicotine use is associated with the development of CVD and is capable of exerting 
cardiovascular effects, including an increase in heart rate and myocardial activity (Kilaru et al., 
2001).  Nicotine has been shown to increase blood pressure (Downey et al., 1981) and impair 
flow-mediated vasodilation by decreasing NO bioavailability (Puranik and Celermaier, 2003).  
Nicotine also affects lipid metabolism by increasing LDL-cholesterol and decreasing HDL-
cholesterol, resulting in higher levels of oxidised LDL (OxLDL) (Clutte-Brown et al., 1986, 
Harats et al., 1989). 
In view of the above, this dissertation set out to explore the putative vascular, endothelial and 
metabolic protective effects of two compounds, viz. rooibos and melatonin in male Wistar rats 
exposed to nicotine administration. Both the indigenous South African shrub, rooibos, and the 
hormone melatonin (which is also pharmaceutically synthesised) are known antioxidants and 
possess properties that could modulate nicotine-induced vascular injury.  Rooibos is a popular 
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herbal beverage, of which both fermented and unfermented forms exist.  Rooibos possesses 
biological properties (Robak and Gryglewski, 1996) and exerts potent antioxidant, immune-
modulating and chemo-protective actions (McKay and Blumberg, 2007).  Both fermented and 
unfermented rooibos are able to increase plasma antioxidant systems (Villano et al., 2010), 
while it has been shown that consumption of fermented rooibos can improve the lipid profile 
and redox status (Marnewick et al., 2011).  Cardioprotective effects of rooibos have previously 
been demonstrated in both human and animal studies (Marnewick et al., 2011, Pantsi et al., 
2011), as well as in in vitro models (Dludla et al., 2014), however, the effects of rooibos on 
endothelial and vascular health are lacking.  Melatonin, the hormone responsible for 
controlling circadian rhythms, is secreted in a variety of organs and tissues in addition to the 
pineal gland (Claustrat et al., 2005, Slominski et al., 2012).  Melatonin is involved in many 
physiological processes in humans and animals, including blood pressure control, regulation 
of the immune response and free radical scavenging (Hardeland et al., 2006, Rodella et al., 
2013).  The chronic administration of melatonin under experimental conditions was 
demonstrated to be cardioprotective, which can be attributed to its free radical scavenging and 
antioxidant properties (Lochner et al., 2006, Nduhirabandi et al., 2011). 
This dissertation made use of an in vivo model of male Wistar rats and an ex vivo model of rat 
aortic ring segments, complemented by an in vitro model of cultured aortic endothelial cells.  
Biometric data and fluid intakes, blood pressure measurements, vascular function supported 
by in vitro investigations, as well as antioxidant enzyme activity and oxidative stress status, 
inflammatory cytokines and serum lipids were determined as measures of the effects of 
nicotine in the rat model.  The effects of nicotine co-treated with rooibos (fermented and 
unfermented) or melatonin were assessed according to the same endpoints to determine 
whether the observed nicotine-induced effects could be ameliorated. 
 
4.1. Phytochemical Content of Rooibos 
Analysis of 2% RF and 2% RUF used in our study revealed a significantly higher soluble solid, 
total polyphenol and flavanol content in RUF, however, RF had a significantly higher flavonol 
content (Table 3.1, Table 3.3).  The main difference between RUF and RF was in the 
aspalathin and nothofagin contents, which was considerably higher in RUF (Table 3.5).  This 
is consistent with previous findings, since it has been shown that the amount of aspalathin can 
decrease by almost 98% during fermentation (Schulz et al., 2003).  Another notable difference 
in the composition of rooibos used in the present study is the presence of the antioxidant and 
free radical scavenger, ferulic acid in RF, but not in RUF.   
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Studies into the bioavailability of rooibos flavonoids are scarce, however, certain compounds, 
including aspalathin and nothofagin have been analysed in humans.  It was shown that 
flavonoids from both fermented and unfermented rooibos have a low bioavailability (Stalmach 
et al., 2009, Courts and Williamson, 2009).  In another human study, unfermented rooibos and 
an isolated active fraction of unfermented rooibos were administered to healthy male 
volunteers and urine and blood samples collected and analysed.  Intact aspalathin and 
nothofagin, as well as metabolites of aspalathin and nothofagin were identified in urine 
samples, while the main metabolite excreted was methylated aspalathin.  In plasma, 
unchanged rooibos flavonoids (including aspalathin) from unfermented rooibos were detected 
in trace quantities (Breiter et al., 2011).  It has also been shown that most aspalathin 
metabolites are excreted within five hours of rooibos consumption in humans, which suggests 
absorption in the small intestine.  It has been suggested that most rooibos flavonoids pass 
through from the small intestine to the large intestine, where it comes into contact with colonic 
microflora, which cleave flavonoids to produce low molecular weight phenolic acids (Stalmach 
et al., 2009).  Furthermore, it has been suggested that these catabolites are absorbed into the 
portal vein, pass through the body and then excreted (Roowi et al., 2009).       
 
4.2. In vivo and ex vivo Investigations: Pilot Study 
Prior to investigating the effects of rooibos and melatonin, a pilot study was undertaken to 
determine the optimal injury-inducing nicotine concentration in our experimental setting.  
According to Benowitz and Jacob (1999), the daily nicotine intake of habitual smokers is in the 
range of 1 mg/kg bw/day nicotine.  A dose as low as 0.6 mg/kg bw/day nicotine, which is 
equivalent to that of a light smoker, has been used to demonstrate that chronic nicotine 
administration could impair aortic reactivity in Sprague-Dawley rats (Zainalabidin et al., 2014).  
A dose of 2 mg/kg bw/day nicotine was utilised in Wistar rats over a four week treatment period 
to induce vascular endothelial dysfunction.  Treatment with benfotiamine was able to attenuate 
nicotine-induced vascular endothelial dysfunction, where reduction of oxidative stress and 
enhanced generation of NO was suggested as mechanisms of action (Balakumar et al., 
2008b).  Therefore, we utilised dosages of 1 mg/kg bw/day nicotine and 2 mg/kg bw/day 
nicotine in our pilot study. 
Endpoints examined included biometric measurements and fluid intakes, blood pressure, 
vascular function, as well as lipid peroxidation.  At the end of the six week treatment period, 
fluid intake was the only endpoint to be significantly affected.  Both 1 mg/kg bw/day and 2 
mg/kg bw/day nicotine resulted in a significant reduction in mean daily fluid intake when 
compared to the saline vehicle control (Fig 3.2), which agrees with previous findings of studies 
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that showed a reduction in water intake in nicotine-exposed rats (Clarke and Kumar, 1984).  
From the pilot study findings, is seems that relatively low nicotine concentrations, were not 
sufficient to induce injury in the majority of the endpoints in young, healthy male rats over the 
treatment period.  
Based on these results, it was decided to perform the main study with a higher nicotine 
concentration, namely 5 mg/kg bw/day.  A nicotine dose of 5 mg/kg bw/day has previously 
been used over a treatment period of five weeks and demonstrated that the rate of endothelial 
cell loss was greater in the nicotine-affected endothelium compared to untreated control 
(Zimmerman and McGeachie, 1985). 
 
4.3. In vivo and ex vivo Investigations: Main Study 
4.3.1. Biometric Measurements and Fluid Intake 
At the end of the six week treatment period, all groups receiving nicotine (nicotine, NRF, NRUF 
and NMel) had a significantly lower mean body weight when compared to the veh control, 
water control, RF and RUF groups (Fig 3.6).  In addition, the mean body weight gain in the 
water control, RF and RUF treatment groups were also significantly increased when compared 
to the veh control and Mel groups.  The lower mean body weight gain of nicotine and nicotine 
co-treatment groups are consistent with previous observations (Kramer et al., 2007, Audi et 
al., 2006, Rezvanipour et al., 2011).  A lower mean body weight gain in nicotine treated rats 
is often linked to a reduction in food consumption (Ijomone et al., 2014).  However, food intake, 
which is a helpful parameter in explaining body weight, was not measured in the current study.  
In an experimental model of chronic nicotine administration in rats, it was shown that a 
reduction in body weight can, in part, be linked to nicotine’s actions on catecholamenergic 
neurons within or extending through the perifornical hypothalamus (PFH) (Kramer et al., 
2007).  These findings were supported by studies demonstrating that the administration of a 
nicotine receptor antagonist, mecamylamine (MEC), could prevent reduced food intake and 
reduced body weight associated with nicotine administration (Guan et al., 2004). 
In a previous study chronic melatonin administration in rats lead to reduced body weight gain, 
without having an effect on metabolism.  In the same study, melatonin did not influence food 
or fluid intake (Terrón et al., 2013).  Chronic melatonin consumption has also been shown to 
reduce body weight gain and visceral adiposity in a rat model of prediabetic diet-induced 
obesity (Nduhirabandi et al., 2011).  Nicotine administration has also been shown to affect 
body composition by reducing visceral adiposity.  Therefore, a reduction in visceral adiposity 
could account for reduced body weight gain in the nicotine, as well as melatonin treatment 
groups.  Rooibos has been shown to have anti-obesity potential in hyperlipidaemic mice, 
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where the activation of AMP-activated protein kinase (AMPK) and resulting regulation of 
cellular energy homeostasis was suggested to be a possible mechanism for the amelioration 
of metabolic disturbances (Beltrán-Debón et al., 2011).  The anti-obesity potential of rooibos 
is supported by an in vitro model of adipocyte differentiation, in which fermented rooibos was 
able to inhibit adipogenesis and affect adipocyte metabolism (Sanderson et al., 2014).  It is 
therefore not surprising that melatonin and rooibos co-treatment was unable to counter the 
effects of nicotine in the NMel, NRF and NRUF groups.  Furthermore, the reduced mean 
weight gain observed in the Mel group, when compared to the RF and RUF could indicate that 
melatonin has a greater potential for reducing body weight gain.   
In view of nicotine’s known cardiac and hepatic effects, it was decided to investigate whether 
nicotine administration exerted any macroscopic changes, as determined by changes in the 
heart and liver weights of the rats.  Studies examining the heart weight/body weight and liver 
weight/body weight ratios are lacking in the context of nicotine co-treated with either rooibos 
or melatonin.  Overall, differences in mean heart weight/body weight and mean liver 
weight/body weight were modest and nicotine treatment had no significant effect when 
compared to its vehicle control, indicating that the differences observed might not be of 
physiological relevance (Fig 3.7 and Fig 3.8).  Cigarette smoke exposure has previously been 
shown to increase heart weights in male and female rats in 13-week smoke exposure studies 
(Gaworski et al., 1998, Heck et al., 2002), while a moderate increase in heart weight/body 
weight ratio has been observed in mice, which was attributed to the potential anorectic effects 
of nicotine (Colombo et al., 2013).  Nicotine is metabolized extensively by the liver and nicotine 
treatment for 60 days has previously been shown to increase liver weights in rats, which was 
attributed to cellular damage leading to the accumulation of lipids in hepatic cells over long-
term nicotine exposure (Iranloye and Bolarinwa, 2009).  The mean daily fluid intake of the 
nicotine treatment group was significantly reduced compared to the veh control group (Fig 
3.9), which is consistent with previous findings where subcutaneous nicotine administration 
was able to depress water intake in rats, where water retention was suggested to supress fluid 
intake (Clarke and Kumar, 1984).  The reduced mean daily fluid intake observed in the nicotine 
treated animals was not affected by co-treatment with RF or RUF; however, melatonin co-
treatment was able to restore nicotine’s effects on fluid intake to veh control levels.  While this 
is an interesting finding, it does not contribute to the understanding of the modulating 
properties of melatonin in the context of this study.  Melatonin has previously been shown to 
temporarily increase water intake in male Wistar: Han rats treated with 4 µg/ml of melatonin, 
when compared to tap water controls (Kassayová et al., 2006).  The reduced fluid intake of 
the water control group is an unexpected finding.  The water control group did not present with 
reduced mean weight gain and had the second highest mean weight gain at the end of the six 
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week treatment period.  The gain in body weight could be attributed to higher food 
consumption than groups with a lower mean weight gain at the end of the treatment period.  
Rats had free access to standard rat chow, which has a moisture content of approximately 
12% (Allers et al., 2008).  Therefore, when more food is consumed, moisture is also taken in, 
which could explain why rats in the water control group had a lower mean fluid intake.  Once 
again, monitoring food consumption would have been a valuable tool in explaining findings.  
A reduction in body weight associated with nicotine administration has been directly linked to 
supressed food intake (Bellinger et al., 2003).  The ability of nicotine to reduce food and fluid 
intake is not completely understood, but it has been demonstrated that nicotine reduces food 
intake by acting on nicotine receptors located in brainstem neurons, indicating that nicotine 
may act to increase satiety (Guan et al., 2004).  In a study which aimed to examine the effect 
of subcutaneous nicotine administration on food and water intake, both food and water intake 
were supressed.  It was suggested that nicotine can supress fluid intake by promoting water 
retention.  Rats were also observed to refrain from drinking water for approximately two hours 
after subcutaneous injection with nicotine (Clarke and Kumar, 1984). 
 
4.3.2. Blood Pressure 
In the present study, blood pressure was non-invasively measured by means of the CODATM 
tail-cuff system.  The accuracy of the CODATM VPR non-invasive blood pressure monitoring 
system has been verified for blood pressure measurements in rodents over the physiological 
range of blood pressure (Feng et al., 2008).  Blood pressure measurements using the CODATM 
system do not require animals to be sedated or fitted with surgical implants.  Our data show 
that blood pressure was significantly increased in the nicotine treatment group when compared 
to the veh control group (Fig 3.10, Fig 3.11, Fig 3.12) and that melatonin co-treatment 
significantly decreased mean diastolic pressure and mean arterial pressure compared to the 
nicotine treatment group.  Unexpectedly, mean systolic pressure was significantly increased 
in the water control and RUF treatment groups when compared to the veh control group. 
Chronic nicotine exposure has been shown to lead to hypertension through various 
mechanisms (Balakumar and Kaur, 2009).  Nicotine can elevate blood pressure indirectly by 
acting as a sympathomimetic agent by releasing catecholamine locally from adrenergic axon 
terminals (Mayhan and Sharpe, 1999, Benowitz, 2001).  Nicotine has also been shown to play 
a modulating role in the renin angiotensin aldosterone system (RAAS), whereby nicotine 
decreased angiotensin converting enzyme 2 (ACE 2) levels in an in vivo model (Ferrari et al., 
2007).  ACE 2 is responsible for converting angiotensin-II (Ang-II) to angiotensin 1-7 (Ang 1-
7).  Ang 1-7 have vasodilatory and anti-proliferative effects, which are important in the control 
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of blood pressure (Balakumar et al., 2008a).  In addition to preventing the favourable 
conversion of Ang-II to Ang 1-7, nicotine is also capable of increasing plasma levels of the 
vasoconstrictor peptide, arginine vasopressin (Yu et al., 2008), as well as upregulating 
endothelin-1 (ET-1), which is involved in vasoconstriction and vascular remodelling (Letizia et 
al., 1997, Takashi et al., 2004).  The increase in ROS associated with nicotine results in a 
decrease in the bioavailability of NO (Toda and Toda, 2010), leading to an upregulation of 
Ca2+ channels and downregulation of Ca2+-active K+ (BK) channels, thereby downregulating 
NO-induced vasorelaxation (Gerzanich et al., 2001).  As such, blood pressure is an important 
and multi-faceted indicator of vascular health in nicotine exposure.  As observed in the present 
study, chronic exposure to nicotine has been shown to significantly increase systolic blood 
pressure in rats, as measured by the tail cuff method (Moon et al., 2013).  A significant 
increase in blood pressure was also reported in a nicotine treatment group in a Wistar rat 
model of hypercholesterolemia (Tamaoki et al., 2009).  
Melatonin has previously been shown to play an important role in controlling blood pressure 
(Rodella et al., 2013).  Vascular relaxation after acute melatonin administration has been 
shown to be related to a decreased oxidative load, increased NO concentration and increased 
cGMP levels in smooth muscle cells (Anwar et al., 2011).  Chronic administration of melatonin 
has also been shown to be advantageous in blood pressure control.  In patients with metabolic 
syndrome (MS), two months treatment with melatonin lowered systolic and diastolic blood 
pressure in human volunteers.  The reduction in blood pressure was attributed to the activation 
of eNOS and increase in NO synthesis (Kozirog et al., 2010).  Melatonin also reduced blood 
pressure in adult spontaneously hypertensive rats with established hypertension after a six 
week treatment period, a result linked to enhanced NOS activity and reduced ROS 
(Pechánová et al., 2007).   
The increase in mean systolic pressure in the water control and RUF treatment groups could 
be explained by a relative lack in handling these groups.  Rats not receiving daily 
subcutaneous injections were subject to less handling procedures when compared to rats 
receiving daily injectable treatments.  It has been shown that rat handling and cage change 
are capable of causing an elevated heart rate and blood pressure levels for up to five hours 
(Meller et al., 2011).  Thus, in future studies, additional care should be given to equalise 
handling procedures between groups.  However, mean diastolic pressure and mean arterial 
pressure were not increased in the water control and RUF treatment groups, while the RF 
group did not present with an increase in blood pressure when compared to any of the other 
groups.  As previously mentioned in the results chapter, it is important to note that blood 
pressure measurements had to be discontinued during the course of the animal studies due 
to the unanticipated renovations at the Central Animal Housing Unit of the Faculty of Medicine 
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and Health Sciences, which resulted in high noise levels and interruptions that were not 
conducive to performing proper blood pressure measurements on the animals. This resulted 
in incomplete measurements for some of the treatment groups, and no measurements for the 
Mel and NRF groups. 
 
4.3.3. Vascular Function 
In our experimental setting, aortic rings harvested from the nicotine treatment group showed 
a significant pro-contractile response to Phe administration when compared to the veh control 
group, however, no significant effects were observed in response to ACh-induced 
vasorelaxation compared to the veh control group (Fig 3.13, Fig 3.14). Our data also show 
that aortic rings harvested from Mel treatment rats demonstrated a significantly greater anti-
contractile response when compared to the water control, RF and RUF treatment groups (Fig 
3.15).  In terms of the ACh-induced relaxation studies, aortic rings from the Mel, RF and RUF 
groups showed a significant pro-relaxation response when compared to the water control (Fig 
3.16). In the co-treatment experiments, melatonin, RF and RUF co-treatment induced 
significant anti-contractile responses when compared to the nicotine treatment group.  
Furthermore, aortic rings harvested from the NMel group also showed additional anti-
contractile responses when compared to NRF and NRUF groups (Fig 3.17).     
Pro-contractile and anti-relaxation effects of nicotine in aortas have previously been 
demonstrated, where oxidative damage, resulting in impaired integrity of the vascular 
endothelium was suggested as possible mechanism of action (Chakkarwar, 2011, Tao et al., 
2013, Şener et al., 2005).  Blood vessels undergo adaptive remodelling (angioadaptation) in 
response to various hemodynamic stimuli and can contribute to the pathophysiology of CVD 
(Pries et al., 2005).  Chronic nicotine administration has been shown to cause important 
changes to the cytoarchitecture of rat aortas.  Changes include injury of the endothelium, loss 
of elastic properties, as well as an increase in the amount of connective tissue (Rodella et al., 
2010).  Aortic remodelling in a rat model of chronic nicotine administration has been examined 
by Zainalabidin et al (2014).  Nicotine treated rats showed an increase in blood pressure and 
pulse pressure when compared to the control.  Aortas from nicotine treated rats showed an 
increase in tunica media thickness and decrease in lumen diameter, vascular remodelling 
properties which could help to explain nicotine-induced hypertension.   
In a previous study where chronic nicotine treatment in Wistar rats was shown to exert a pro-
contractile response to Phe administration, as well as reduced endothelium-dependent 
relaxation response to ACh administration in vascular contraction / relaxation experiments, 
nicotine administration was also associated with an increase in lipid peroxidation and tissue 
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collagen content of aortic tissue (Şener et al., 2005).  The pro-contractile response could be 
attributed to vascular remodelling associated with chronic nicotine exposure, such as loss in 
elasticity, increase in connective tissue and decrease in lumen diameter.  These factors also 
underlie the increase in blood pressure, as seen in mean systolic, mean diastolic and mean 
arterial pressure in the nicotine group when compared to the veh control. 
Even though it was not necessarily expected that melatonin and rooibos would improve the 
vascular function when compared to an untreated control, it could indicate that both melatonin 
and rooibos have inherent antioxidant potential.  These findings could also suggest that 
melatonin and rooibos are capable of activating eNOS, thereby increasing the bioavailability 
of NO. 
Pro-relaxation findings in the nicotine co-treatment groups (NMel and NRF) indicate that 
melatonin and fermented rooibos were able to counter-act the harmful effects of nicotine on 
vascular function.  ACh relaxation is dependent on eNOS activation and the subsequent 
release of NO, which diffuses into underlying smooth muscle cells, leading to vascular 
relaxation.  Thus, the significant pro-relaxation responses of the NMel and NRF groups could 
be indicative of enhanced eNOS activation, resulting in an increase in the release of 
vasoactive NO. 
The modulating effects of rooibos treatment in a model of nicotine-induced vascular injury 
have, to our knowledge, not previously been investigated by means of isometric tension 
studies in vascular ring segments. The data on the vascular effects of rooibos presented in 
this dissertation are therefore novel.  While studies into the modulating effects of rooibos in 
terms of vascular contraction and relaxation are lacking, our results could be explained by its 
flavonol content.  The flavonol content of rooibos underlies its antioxidant and anti-
inflammatory activities, and could also help to explain its vaso-relaxant activities (Chan et al., 
2000, Perez-Vicaino et al., 2006). 
On the other hand, the modulating effects of melatonin on the contraction / relaxation of aortas 
excised from rats receiving chronic nicotine administration have previously been 
demonstrated.  Melatonin administration in nicotine-treated animals restored vascular function 
and lead to a reduction in tissue damage in the bladder and aorta, which was associated with 
a significant reduction in lipid peroxidation (Şener et al., 2004).  Chronic melatonin treatment 
has previously been shown to improve the ACh-induced relaxation response in normotensive 
Wistar-Kyoto (WKY) rats, when compared to untreated controls.  It was suggested that 
melatonin could enhance endothelium-dependent vasodilation, possibly due to an 
enhancement of the vascular NOS pathway (Girouard et al., 2001).    
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The first pro-relaxation action of melatonin in aortic ring studies was demonstrated in rabbit 
aorta.  Melatonin was capable of inhibiting contractile responses to 5-hydroxytryptamine (5-
HT), whereby increased levels of cGMP was proposed as a possible mechanism of action 
(Satake et al., 1991a).  A subsequent study in rat aortas confirmed the vaso-relaxing response 
of melatonin to 5-HT.  Removal of the endothelium partially inhibited the vaso-relaxing effect 
of melatonin, indicating the endothelium dependent action of melatonin (Satake et al., 1991b).  
Chronic melatonin treatment was shown to reduce blood pressure and improve ACh-induced 
relaxation in aortas from spontaneously hypertensive rats, where an improved vascular NOS 
pathway activity was suggested as mechanism for hypotensive and pro-relaxation effects of 
melatonin (Girouard et al., 2001).  The ability of melatonin to decrease Phe-induced 
vasoconstriction and its pro-relaxation response to ACh was also demonstrated in aortas of 
streptozotocin-diabetic rats (Reyes-Toso et al., 2002).  
Melatonin is a potent free radical scavenger (Tan et al., 1993) that has been shown to reduce 
the degree of histological aorta damage, which is associated with nicotine use, including 
damage in the tunica intima and tunica media (Rodella et al., 2010a).  It was proposed that 
melatonin’s beneficial effects on nicotine-induced vasculopathy could be attributed to blocking 
the activation of extracellular signal regulated kinase (ERK) and other signalling pathways in 
which the enzyme is involved (Rodella et al., 2010b).     
As far as we are aware, the effects of fermented rooibos as treatment for nicotine induced 
injury remain unexamined in in vitro models of rat aortic endothelial cells.  Our data show that 
nicotine was capable of reducing NO production in AECs (Fig 3.19), which was associated 
with increased cell death, both in terms of necrosis and apoptosis (Fig 3.20, Fig 3.21).  Nicotine 
has been widely used in in vitro studies and for a wide variety of applications and injury states 
(Tonnessen et al., 2000) where cell types ranged from smooth muscle cells (Jacob-Ferreira 
et al., 2010) to human aortic endothelial cells (HAECs) (Alamanda et al., 2012), and human 
umbilical vein endothelial cells (HUVECs) (Albaugh et al., 2001).  Nicotine treatment has been 
shown to induce injury in different cell types.  In endothelial cell models, nicotine treatment 
resulted in changes to endothelial cell surface intercellular adhesion molecule (ICAM) 
expression in HUVECs (Speer et al., 2002). In cultured human endothelial cells, nicotine 
increased endothelin production (Lee and Wright, 1999) and induced E-selectin transcription 
in HAECs (Alamanda et al., 2012).  Chronic nicotine treatment has been shown to decrease 
NO release, which correlated with a significant downregulation in eNOS gene expression in 
HUVECs when compared to control (Park et al., 2011).  Nicotine has also been shown to 
invoke endothelial cell apoptosis in HUVECs (Wang et al., 2011) and inhibit cell proliferation, 
which is suggestive of cytotoxicity (An et al., 2014). 
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Based on the significant anti-contractile and pro-relaxation responses observed with RF co-
treatment in our aortic ring experiments, nicotine-treated AECs were pre-treated with RF to 
determine if it could affect the injury model.  Pre-treatment of AECs with RF significantly 
improved NO production in nicotine-injured cells (Fig 3.24), however necrosis was unaffected 
(Fig 3.25). The ability of RF to counter-act the deleterious effects of nicotine on NO production 
support the findings observed in aortic rings and indicate the activation of eNOS as a possible 
underlying mechanism to improved vascular function seen in the RF group.  As far as we are 
aware, these data are novel.  
Rooibos and some of its compounds have recently been examined in human umbilical vein 
endothelial cells (HUVECs) and under varying conditions.  Aspalathin and nothofagin, the two 
major dihydrochalcones found in unfermented rooibos have been investigated for their anti-
inflammatory effects.  Aspalathin and nothofagin were both found to inhibit lipopolysaccharide 
(LPS)-induced barrier disruption, expression of cell adhesion molecules and adhesion and 
migration of neutrophils to human endothelial cells (Lee and Bae, 2015).  Aspalathin and 
nothofagin have also been used to demonstrate their inhibitory effects on endothelial protein 
receptor shedding in HUVECs (Kwak et al., 2015).     
 
4.3.4. Antioxidant Enzyme Activity and Oxidative Stress Status 
SOD is regarded as one of the primary defences against ROS and is responsible for the 
conversion of O2•- to H2O2 and O2.  Accumulation of H2O2 leads to the up-regulation of 
antioxidant enzymes CAT and GPx (Nelson et al., 2006, Goyal and Basak, 2010).  An increase 
in SOD activity can thus be regarded as a crucial first step in the antioxidant defence 
mechanisms, by enhancing oxidative stress signals that stimulate other antioxidant enzymes 
(Vouldoukis et al., 2004, Cloarec et al., 2007).  CAT accelerates the decomposition of H2O2 to 
H2O (Li et al., 2014), while GPx reduces H2O2 to H2O and lipid hydroperoxidases to alcohols 
(Lubos et al., 2011).  It is important to note that ROS can reduce and eliminate the protective 
abilities of NO, highlighting the importance of an improvement in antioxidant capacity in the 
presence of nicotine. 
The mitochondria supply approximately 90% of the ATP required by the myocardium, which 
is a highly energy demanding tissue.  Under physiological conditions up to 2% of oxygen can 
be converted to O2•-mainly at complex I and III of the electron transport chain (ETC) (Boveris 
and Chance, 1973).  To combat ROS production, mitochondria rely on detoxifying enzymes 
and non-enzymatic antioxidants, of which MnSOD is a first line defence.  MnSOD converts 
O2•- into H2O2, which can be detoxified further by GPx and peroxiredoxine (Prx-III) (Andreyev 
et al., 2005).  It is also possible for O2•- to be released in the membrane space, where 
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(CuZnSOD) causes conversion to H2O2, as well as for cytochrome c to scavenge O2•- which 
is leaked into the intermembrane space (Pasdois et al., 2011).  Since mitochondria are a major 
site for the generation of ROS, dysfunction in mitochondria can increase the risk for a number 
of diseases, including CVD (Ajith and Jayakumar, 2014).  The removal of dysfunctional 
mitochondria through autophagy is important in the maintenance of cell viability, however, 
prolonged over-production of ROS can cause a decline in the removal process, which could 
be involved in the development of CVD (Dutta et al., 2012).   
SOD is found in high concentrations in the heart and liver.  Different types of SODs have been 
characterized according to their metal content, of which copper-zinc-containing SOD 
(CuZnSOD) is found in the cytosol and manganese-containing SOD (MnSOD) in the 
mitochondria (Marklund, 1980).  Since mitochondria are abundant in cardiac tissue, it was 
decided to examine the SOD activity of heart cytosolic and heart mitochondrial fractions 
separately. 
In the heart cytosolic fraction, the SOD activity of the RF treatment group was significantly 
increased when compared to the water control, RUF, Mel, NRF and NMel treatment groups.  
However, SOD activity in the heart mitochondrial fraction of the RF group was significantly 
reduced when compared to the water control, Mel, NRF, and NRUF groups.  The SOD activity 
of the NRUF group was also significantly increased in the heart mitochondrial fraction, when 
compared to the veh control group (Fig 3.26, Fig 3.27).  In liver tissue homogenates, the SOD 
activity of the RF treatment group was significantly increased compared to the water control, 
Mel and nicotine groups.  The SOD activity of the NRF and NMel groups were also significantly 
increased compared to the nicotine group, indicating an improvement in antioxidant capacity 
(Fig 3.28). 
No significant differences were found between the nicotine treatment group and the veh 
control group in either fraction of heart tissue homogenates, however SOD activity was 
significantly reduced in the nicotine treatment group of liver tissue homogenates when 
compared to the veh control group (Fig 3.26, Fig 3.27, Fig 3.28).   
CAT activity was significantly reduced in the nicotine treatment groups in both heart cytosolic 
fraction and liver tissue, when compared to veh controls.  In the heart cytosolic fraction, CAT 
activity was increased in the NRUF and NMel groups, as well as RF and Mel groups when 
compared to the nicotine treatment group (Fig 3.29).  CAT activity was significantly increased 
liver tissue homogenates in the Mel, NRF and NMel treatment groups, when compared to the 
nicotine treatment group (Fig 3.30).  However, no significant differenced were found between 
GPx activity of the respective treatment groups (Fig 3.31). 
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Nicotine treatment has previously been shown to decrease SOD activity in both liver and heart 
tissue, when compared to untreated controls (Gumustekin et al., 2010, Neogy et al., 2008).  
Similarly, CAT activity has previously been shown to be reduced by nicotine treatment in male 
Wistar rats, when compared to untreated controls (Neogy et al., 2008).  The increased SOD 
activity in the RF treatment group in both heart cytosolic tissue and liver tissue, when 
compared to the water control group could be attributed to the pro-antioxidant properties of 
rooibos.  However, the SOD activity in heart mitochondrial tissue of the RF group was 
significantly reduced compared to several other groups, including the water control, which is 
in contrast to findings in heart cytosolic tissue and liver tissue.  Signalling pathways associated 
with ROS are complex and compartmentalized, which could explain why findings are not 
necessarily consistent between different tissue fractions (Brown and Griendling, 2015).  In 
addition, the bioavailability of rooibos and its various polyphenolic constituents and their exact 
mechanisms of action have not been fully elucidated (Stalmach et al., 2009, Courts and 
Williamson, 2009). 
In our experimental setting, RF increased SOD activity in the heart cytosolic fraction and liver 
tissue, indicating enhanced antioxidant capacity, which is a hallmark of rooibos.  In liver tissue, 
co-treatment of nicotine with RF and Mel (NRF and NMel groups) showed significantly 
increased SOD activity when compared to the nicotine treatment group.  Furthermore, CAT 
activity in liver tissue of the NRF and NMel groups were also increased, which correlates with 
the increase observed in SOD activity. 
Rooibos has been shown to have the potential to increase the activity of antioxidant enzymes, 
including SOD and GPx, in diabetic rats (Ayeleso et al., 2014).  A four week rooibos treatment 
period was able to attenuate SOD, CAT and GPx activities in rat brain extracts in an 
immobilization stress model (Hong et al., 2014).  Rat serum SOD levels were increased after 
a four week treatment with rooibos, when compared to untreated controls, an action attributed 
to the flavonoid content in rooibos.  Furthermore, SOD levels were significantly higher in 
rooibos treated animals, using a rat colitis model.  In the same study, 8-hydroxy-2’-
deoxyguanosine (8-OHdG) levels in urine were significantly decreased in the rooibos 
treatment group when compared to controls, suggesting that rooibos is effective in reducing 
DNA damage caused by oxidative reactions (Baba et al., 2009).  The composition of fermented 
rooibos and unfermented rooibos differ in terms of flavonol content, which could lead to 
different modulating capacities.  However, investigations comparing the modulating effects of 
fermented rooibos to unfermented rooibos are limited.  
Melatonin has previously been shown to increase SOD activity in both the liver and lung of 
nicotine-treated rats over a treatment period of four weeks (El-Sokkary et al., 2007).  Melatonin 
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also increased SOD activity in a fructose-induced model of metabolic syndrome in a rat model.  
However, CAT activity was unchanged in all treatment groups after the eight week treatment 
period (Demirtas et al., 2015).  In a rat model of renovascular hypertension, a nine week 
treatment period with melatonin improved cardiovascular function, which was associated with 
an increase in SOD and CAT activity (Ersahin et al., 2009).  Melatonin was also shown to have 
a protective role in myocardial oxidative damage in a mercury-induced murine model, which 
was associated with an increase in SOD activity (Jindal et al., 2010).  
TBARS and CD levels are both indicators of lipid peroxidation.  Lipid peroxidation leads to the 
rearrangement of polyunsaturated fatty acid double bonds, leading to the formation of CD, 
which indicates primary lipid peroxidation, while measurement of TBARS levels is the method 
most frequently used to determine lipid peroxidation and indicates secondary lipid 
peroxidation.  In the current study, analysis of CD levels did not result in any significant 
difference between treatment groups.  TBARS levels were increased in the nicotine treatment 
group and co-treatment with melatonin (NMel group) significantly reversed TBARS levels, 
indicating a reduction in oxidative stress (Fig 3.33).  Nicotine has previously been shown to 
increase lipid peroxidation (MDA levels) in Sprague-Dawley rats, when compared to untreated 
controls in a study which investigated the effects of vitamin E and an extract of Hippophea 
rhamnoides on nicotine-induced oxidative stress (Gumustekin et al., 2010), thus supporting 
our findings.   
Overall, the above data support the findings observed in the aortic ring studies (section 2.3), 
whereby RF and Mel were capable of modulating the harmful effects of nicotine in vascular 
function (NRF and NMel groups vs nicotine group).  An increase in SOD activity and CAT 
activity (NRF and NMel groups vs nicotine group), reduction in TBARS levels (NMel group vs 
nicotine group) and anti-contractile and pro-relaxation responses (NRF and NMel groups vs 
nicotine group) could indicate that RF and Mel were capable of reducing ROS and, in turn, 
enhancing the release of NO, restoring the balance of the release of vasoactive factors.  
 
4.3.5. Inflammatory Marker (CRP) Levels 
CRP is a sensitive, but non-specific marker of the acute inflammatory response and is directly 
involved in the development of atherosclerosis (Mao et al., 2012).  Nicotine treatment alone 
had no effects on serum CRP levels (Fig 3.34). Furthermore, CRP levels remained unchanged 
in nicotine-treated rats that received RF, RUF and Mel co-treatment. Treatment with RUF and 
Mel significantly decreased CRP levels compared to water controls.  CRP is involved in the 
proliferation and migration of VSMCs and mediates the uptake of LDL by macrophages, in 
turn promoting the formation of foam cells (Zwaka et al., 2001).  Even though it was surprising 
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that the CRP levels in the nicotine treatment group did not increase, it has previously been 
demonstrated that nicotine administration in rats were not associated with an increase in CRP 
levels (Cecconi et al., 2008). It is difficult to explain why nicotine treatment had no effect on 
CRP levels in the present study.  Unfortunately, the serum IL-6 and TNF-α levels were not 
available in view of the fact that the concentrations in the samples supplied to the CPGR were 
below the detectable range as reported to us. This is unfortunate, as information on the levels 
of IL-6 in particular would have been helpful to support the CRP results, since IL-6 is 
responsible for CRP induction in the liver (Kushner et al., 1995).  TNF-α has previously been 
shown to increase in a model of nicotine-treated human THP1 monocytes, which was 
suggested to play a role in the progression of atherosclerosis (Zhou et al., 2013), and is 
implicated in the induction of ED (Cardillo et al., 2006), possibly due to impairment of 
endothelium-dependent and NO-mediated vasodilation.  
 
4.3.6. Serum Lipid Measurements 
No significant differences were found in TC and PL levels between treatment groups (Fig 3.35, 
Fig 3.36), however, TG levels were significantly decreased in the nicotine group compared to 
the veh control, water control, RF and RUF treatment groups (Fig 3.37).  TG concentrations 
were also significantly decreased in the NMel group, when compared to the RUF group.  TG 
levels are typically increased during nicotine exposure (Sudheer et al., 2008), while chronic 
nicotine treatment has been shown to alter lipid metabolism and was associated with an 
increase in TG levels (Ashakumary and Vijayammal, 1997).  It is, however, important to note 
that the nicotine treatment periods in the aforementioned studies were 22 weeks (154 days) 
and 90 days respectively, whereas the nicotine treatment period for our current study was six 
weeks (42 days).  These findings could indicate that the effects of nicotine on lipid metabolism 
develop over time and were not yet apparent after our treatment period. 
 
4.3.7. General Discussion 
The increased oxidative stress associated with nicotine use can lead to a reduction in NO 
bioavailability, impairing endothelium-dependent relaxation.  Our results demonstrate that 
chronically administered nicotine could increase mean systolic, mean diastolic and mean 
arterial blood pressure, as well as exert pro-contractile effects in isolated aortic rings.  The 
ability of nicotine to impair vascular function and damage the endothelium was further 
demonstrated and underscored in a model of cultured AECs, where nicotine treatment 
resulted in a reduction in NO production and increased cell death.  In addition to vascular 
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damage, nicotine administration leads to reduced SOD activity in liver tissue and CAT activity 
in both heart cytosol and liver tissue, as well as increased lipid peroxidation, as determined by 
TBARS levels in serum, all of which suggest that nicotine was capable of inducing oxidative 
stress, which could underlie the mechanisms leading to a disruption in vascular homeostasis 
and, in turn, vascular damage.  The main findings of the in vivo, ex vivo and in vitro nicotine 
treatments are summarised in Figure 4.1. 
Our results indicate that melatonin and rooibos, specifically RF have the potential to combat 
nicotine-induced vascular injury.  The vascular modulating potential of melatonin has 
previously been demonstrated (Anwar et al., 2011; Kozirog et al., 2010; Pechánová et al., 
2007) and could be attributed to its potent free radical scavenging and antioxidant capabilities 
(Hardeland et al., 1993, El-Sokkary et al., 2002), ability to cross biological barriers (Venegas 
et al., 2012) and presence in all bodily fluids, tissues and cellular compartments (Reiter et al., 
2013), making it an ideal candidate to combat increased oxidative stress.  Both melatonin and 
RF demonstrated the ability to restore vascular function in the ex vivo model (anti-contractile 
and pro-relaxation effects in aortic rings) and increase antioxidant defences in the in vivo 
model (increased SOD and CAT activity).  Therefore, based on these findings, it is possible to 
speculate that melatonin and RF exerted their effects via similar mechanisms.  In addition, 
melatonin was capable of reducing lipid peroxidation (TBARS) in nicotine-treated rats.  The 
effects of RF were further demonstrated in the in vitro model of cultured AECs, where RF 
improved endothelial function (increased NO production) in nicotine-injured cells.  The main 
findings of the in vivo and ex vivo nicotine and melatonin co-treatments are summarised in 
Figure 4.2 and the main findings of the in vivo, ex vivo and in vitro nicotine and fermented 
rooibos co-treatments, as well as the main findings for the in vivo and ex vivo nicotine and 
unfermented rooibos co-treatments are summarised in Figure 4.3. 
It is interesting to note that rooibos (RF and RUF) exerted modulating effects in nicotine-
induced vascular injury to varying degrees.  Epidemiological evidence suggests that dietary-
derived antioxidants have potential for disease prevention (Froman et al., 2014) and it has 
been shown that dietary polyphenols can increase endothelium-dependent NO generation by 
modulating cellular sensors for oxidative stress.  NO is capable of reacting with O2•- to form 
peroxynitrite, which can lead to a nuclear accumulation of nuclear factor erythroid 2-related 
factor (Nrf2) (Mann et al., 2007).  Nrf2 is a redox sensitive transcription factor, involved in 
antioxidant response element (ARE) dependent gene expression (Nguyen et al., 2003).  Under 
conditions of oxidative stress, Nrf2 is capable of activating ARE dependent transcription of 
phase II and antioxidant defence enzymes, such as glutathione-S-transferase, GPx and 
heme-oxygenase-1 (Kensler et al., 2007).  In addition, the safety of both fermented and 
unfermented rooibos has previously extensively been investigated in a rat model and no 
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adverse effects were found.  Parameters examined included body weight, liver weight and 
liver and kidney parameters, including total cholesterol, aspartate transaminase and creatinine 
(Marnewick et al., 2003). 
The particularly promising modulating effects of RF when compared to RUF could be attributed 
to the presence of ferulic acid in RF, since no ferulic acid was detected in RUF.  Ferulic acid 
is a potent antioxidant and free radical scavenger (Mancuso and Santangelo, 2014) and has 
been shown to possess blood pressure lowering effects (Suzuki et al., 2002).  It has been 
proposed that ferulic acid has multifactorial vasodilating effects, involving the reduction of 
angiotensin II and activation of eNOS, leading to an increase in NO (Suzuki et al., 2007).  RF 
also had a significantly higher flavonol content, when compared to RUF, which translated to a 
higher daily intake of flavonols in the RF and NRF treatment groups.  The higher flavonol 
content in RF could also help to explain the greater modulating capacity of fermented rooibos.  
These findings suggest that both RF and RUF have the potential to restore vascular 
homeostasis, and in turn, modulate the harmful effect of nicotine in the context of vascular 
injury.  RF specifically presents potential modulating effects, as demonstrated by its anti-
contractile and pro-relaxation effect in aortic rings, and supported by in vitro findings.   
It is possible that melatonin and rooibos exert their effects through different mechanisms, all 
of which would result in a restoration of vascular homeostasis and, in particular, the function 
of NO. 
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Figure 4.1. Summary of findings of in vivo, ex vivo and in vitro nicotine treatment. 
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Figure 4.2. Summary of in vivo and ex vivo findings of nicotine and melatonin co-treatment. 
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Figure 4.3. Summary of findings of in vivo, ex vivo and in vitro nicotine and fermented rooibos 
co-treatment and in vivo and ex vivo nicotine and unfermented rooibos co-treatment. 
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CHAPTER 5: CONCLUSION 
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5.1. General Conclusion 
This study aimed to investigate the modulating effect of rooibos (fermented and unfermented) 
and melatonin in the context of nicotine-induced vascular injury.  Oxidative stress can lead to 
a loss of vascular homeostasis, in particular a reduction in the bioavailability of NO, which can 
lead to the development of ED.  Nicotine exposure is associated with early endothelial 
changes, such as endothelial dysfunction, which is an important precursor of atherosclerosis 
and, in turn, cardiovascular disease.  Therefore, it is important to identify therapeutic 
compounds capable of modulating oxidative stress injury in the context of vascular health, in 
order to reduce or reverse endothelial dysfunction and, in turn, restore vascular homeostasis.  
Both rooibos and melatonin have been shown to possess antioxidant effects.  Rooibos has 
also been shown to have immune-modulating and chemo-protective actions and is capable of 
improving the lipid profile and redox status, while melatonin is involved in many physiological 
processes, including blood pressure control, free radical scavenging and has been 
demonstrated to be cardioprotective.  In order to examine the modulating effect of rooibos and 
melatonin, this study utilised an in vivo model of male Wistar rats and an ex vivo model of rat 
aortic ring segments, complemented by an in vitro model of cultured aortic endothelial cells. 
 
5.1.1. Nicotine-induced Injury 
Firstly, an in vivo model of nicotine-induced vascular injury was established in male Wistar 
rats.  Concentrations of 1 mg/kg bw/day nicotine and 2 mg/kg bw/day nicotine did not result in 
sufficient vascular injury in our experimental setting, with a reduction in fluid intake being the 
only endpoint significantly influenced in nicotine treated groups when compared to the veh 
control group.  Based on these findings, a higher nicotine concentration, namely 5 mg/kg 
bw/day nicotine, was utilised over a six week treatment period.  Nicotine treatment significantly 
influenced biometric parameters and fluid consumption in the animals.  Nicotine increased 
mean systolic, mean diastolic and mean arterial pressure and exerted a pro-contractile 
response in aortic rings, as determined ex vivo isometric tension studies.  The apparent 
harmful vascular effects of nicotine were further underscored in an in vitro model utilising adult 
rat aortic endothelial cells, whereby a 24 hour incubation period with 100 µM nicotine leads to 
reduced intracellular NO levels and increased cell death (necrosis and apoptosis).  
Furthermore, nicotine administration resulted in a decrease in SOD activity in liver tissue and 
decrease in CAT activity in both heart and liver tissue, as well as an increase in lipid 
peroxidation as indicated by TBARS determination in serum.  Based on these results, 5 mg/kg 
bw/day nicotine, subcutaneously administered over a six week treatment period, resulted in 
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significant vascular and endothelial injury, which was associated with increased oxidative 
stress and reduced antioxidant activity. 
 
5.1.2. Modulating Capabilities of Rooibos (Fermented and Unfermented) and Melatonin 
Both melatonin and rooibos were capable of restoring nicotine-induced changes in certain 
endpoints of vascular function and increasing antioxidant activity.  However, fermented and 
unfermented rooibos showed varying degrees of modulation, with the restorative effect of 
fermented rooibos being more pronounced and comparable to the capabilities of the potent 
free radical scavenger and antioxidant, melatonin.  This was demonstrated by an ex vivo 
model of vascular function, as well as in vivo model indicating an increase in antioxidant 
defences.  Additionally, melatonin also decreased lipid peroxidation (TBARS), when compared 
to the nicotine treatment group.  These findings were further substantiated by in vitro 
investigations, where pre-treatment of AECs with RF was capable of restoring NO production 
in nicotine-injured cells.  As far as we are aware, this is the first study to examine the effects 
of rooibos in a model of nicotine-induced injury in AECs.  Unfermented rooibos treatment 
resulted in the modulation of nicotine-induced vascular injury to a lesser degree compared to 
fermented rooibos, and was capable of exerting anti-contractile responses in aortic rings when 
compared to the nicotine treatment group.  Furthermore, treatment with unfermented rooibos 
also increased CAT activity in heart tissue of nicotine-treated animals.   
Melatonin’s modulating capabilities could be attributed to its antioxidant and free radical 
scavenging capabilities.  Melatonin is able to easily cross biological barriers and is present in 
all bodily fluids, tissues and cellular compartments, which could explain its modulating effects 
in different tissues and across different endpoints.  In addition to its potent antioxidant 
properties, other possible mechanisms of action of melatonin include the inhibition of ERK 
activation, reduction in histological aorta damage and enhanced endothelium-dependent 
vasodilation, which would indicate improved vascular NOS pathway activity.  All of the 
abovementioned mechanisms would result in restoring vascular homeostasis and, in 
particular, the release of NO. 
The finding that fermented rooibos was capable of greater modulation of vascular injury was 
somewhat unexpected, since two major dihydrochalcones, namely aspalathin and nothofagin, 
are greatly reduced during the fermentation process.  However, the analysis of the aqueous 
rooibos preparations indicated that fermented rooibos had a higher flavonol content, which 
translated to a higher daily flavonol intake in both the RF and NRF treatment groups.  This 
finding could, in part, help to explain the greater modulating capacity of fermented rooibos.  It 
is possible that rooibos exerts its modulating effects through the transcription factor Nrf2, 
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which has been shown to activate ARE dependent transcription of phase II antioxidant defence 
enzymes, which would combat oxidative stress in order to restore vascular homeostasis.  The 
presence of ferulic acid in fermented rooibos (as shown in the HPLC analysis) could explain 
why fermented rooibos was capable of exerting a greater modulating effect than unfermented 
rooibos, which contained no detectable ferulic acid levels.  Ferulic acid has a multifactorial 
vasodilating effect, whereby angiotensin II is reduced and eNOS activated, leading to an 
increase in NO production.  It should also be considered that antioxidants administered in high 
concentrations may not be beneficial and can exert pro-oxidant effects, which could help to 
explain the lesser modulating capability of unfermented rooibos when compared to fermented 
rooibos in the model of nicotine-induced vascular injury.  However, studies into the 
bioavailability of rooibos, specifically fermented rooibos versus unfermented rooibos, are 
lacking. 
 
5.2. Novel Findings Arising from this Study 
The investigations pertaining to the effects of rooibos on nicotine-induced vascular injury have 
not previously been demonstrated.  The investigations of the current study revealed the 
following novel findings, particularly with regard to fermented rooibos: 
 Improved vascular function as determined by vascular contraction / relaxation 
experiments. 
 Increased NO production in nicotine-injured rat AECs. 
 Improved antioxidant enzyme activity as determined by SOD and CAT. 
 
5.3. Final Conclusions 
Both fermented rooibos and melatonin have the potential to modulate nicotine-induced 
vascular injury and present attractive candidate therapeutic strategies for reducing or 
reversing early endothelial injury, and, in turn, possibly future CVD.  While the modulating 
capabilities of rooibos and melatonin can be linked to their antioxidant properties, it is possible 
that they function through different mechanisms in order to exert their effect.  However, eNOS 
activation and subsequent release of NO could underlie the modulating actions of both rooibos 
and melatonin.  Rooibos and melatonin have both been found to have no adverse effects; in 
addition, fermented rooibos is readily available to consumers and could provide a cost-
effective treatment to reduce cardiovascular risk when using nicotine.  
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5.4. Shortcomings of the Study 
 Blood pressure measurements could not be completed for all treatment groups, due to 
the unexpected renovations undertaken at the animal housing facility. 
 No western blotting analysis of aortic rings performed, which could have supplied more 
information on the underlying cellular mechanisms of the different treatment groups. 
Proteins of interest that would have added value to our understanding of underlying 
mechanisms, include eNOS (main enzyme responsible for endothelial production of 
nitric oxide), PKB/Atk (cell growth and survival protein, upstream activator of eNOS, 
and an important anti-apoptosis protein) and p22phox (marker of NADPH-oxidase 
activity – an important vascular source of ROS and oxidative stress). 
 In vitro investigations into the effect of melatonin on nicotine-injured rat AECs would 
have supplied valuable insights into their cellular mechanisms; these studies could, 
however, not be undertaken due to time and financial constraints.  
 
5.5. Future Directions 
Further investigations into this topic are partially based on the shortcomings of this study and 
would include the following: 
 Western blotting analysis of aortic rings as explained above. 
 Proteomic analysis of aortic rings to explore large-scale protein expression patterns 
and differential protein regulation that could greatly contribute to a better 
understanding and identification of novel cellular pathways and mechanisms involved 
in vascular injury and protection.   
In addition, the following investigations should be considered: 
 Examination of histomorphological changes in aortas, including tunica media thickness 
and lumen diameter, would help to explain changes in blood pressure and vascular 
contraction / relaxation investigations. 
 The combination of rooibos and melatonin as treatment for nicotine-induced vascular 
injury provide a further investigation opportunity.  Since it is possible that rooibos and 
melatonin exert their antioxidant, and indeed vascular modulating effects, through 
different mechanisms, it is possible that co-treatment of rooibos and melatonin in the 
case of nicotine-induced vascular injury could further augment their modulating 
capabilities. 
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 Investigations to determine whether nicotine or nicotine in combination with rooibos or 
melatonin could influence intracellular calcium levels in endothelial cells. 
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5.6. Outputs 
The following outputs were generated from the study: 
 
5.6.1. Conference Contributions 
Presentations: 
Smit-van Schalkwyk M, Windvogel SL, Strijdom H.  Rooibos and melatonin as prospective 
therapies for nicotine induced effects on vascular function: injury models and 
preliminary findings.  42nd Annual Conference of the Physiology Society of Southern Africa; 
2014. 
 
Posters: 
Smit-van Schalkwyk M, Windvogel SL, Strijdom H.  The effects of rooibos (Aspalathus 
linearis) and melatonin on vascular function in a rat model of nicotine-induced vascular 
injury.  59th Annual Academic Day, Faculty of Medicine and Health Sciences, Stellenbosch 
University; 2015. 
 
5.6.2. Postgraduate Student Supervision 
BSc Honours students: 
 Mnr Kevin Els – HonsBSc (Medical Physiology) – Graduated December 2014 
 Ms Zimvo Maqeda – HonsBSc (Medical Physiology) – to graduate December 2015 
 
5.6.3. Successful Applications for Research Grants 
This project was successful in obtaining research grants from the following funding bodies: 
 Harry Crossley Foundation, Stellenbosch University: 2014 – 2015 
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“Three things that never come back: 
the spent arrow; 
the spoken word; 
the lost opportunity.” 
 
William George Plunkett 
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